hydrogen peroxide - Ontology Report

Help | FTP Download | Citing RGD | Contact Us

Keyword

ONTOLOGY REPORT - ANNOTATIONS

Term:	hydrogen peroxide	go back to main search page
Accession:	CHEBI:16240	browse the term
Definition:	An inorganic peroxide that has formula H2O2.
Synonyms:	exact_synonym:	bis(hydridooxygen)(O--O); dihydrogen peroxide; dioxidane
	related_synonym:	H2O2; HOOH; InChI=1S/H2O2/c1-2/h1-2H; InChIKey=MHAJPDPJQMAIIY-UHFFFAOYSA-N; Oxydol; [H]OO[H]; [OH(OH)]; dihydrogen dioxide
	alt_id:	CHEBI:13354; CHEBI:13355; CHEBI:24637; CHEBI:44812; CHEBI:5586
	xref_casrn:	7722-84-1
	xref:	Beilstein:3587191 "Beilstein Registry Number"; ChEMBL:295106 "ChEMBL COMPOUND"; ChemIDplus:7722-84-1 "CAS Registry Number"; Gmelin:509 "Gmelin Registry Number"; KEGG COMPOUND:7722-84-1 "CAS Registry Number"; KEGG COMPOUND:C00027 "KEGG COMPOUND"
	xref_mesh:	MESH:D006861
	xref:	MolBase:932 "MolBase"; NIST Chemistry WebBook:7722-84-1 "CAS Registry Number"; PDBeChem:PEO "PDBeChem"
	cyclic_relationship:	is_conjugate_acid_of CHEBI:29192

Rat
Mouse
Human
All
show annotations for term's descendants
Sort by:

hydrogen peroxide
	Symbol	Object Name	GBrowse	Qualifiers	Evidence	Chr	Start	Stop	Reference	Source
G	AASS	aminoadipate-semialdehyde synthase		affects expression	EXP	7	121,713,598	121,784,344	RGD:6480464	CTD
G	ABCC2	ATP-binding cassette, sub-family C (CFTR/MRP), member 2		affects expression	EXP	10	101,542,463	101,611,662	RGD:6480464	CTD
G	ABCC3	ATP-binding cassette, sub-family C (CFTR/MRP), member 3		affects expression	EXP	17	48,712,218	48,769,063	RGD:6480464	CTD
G	ABCF2	ATP-binding cassette, sub-family F (GCN20), member 2		affects expression	EXP	7	150,904,923	150,924,317	RGD:6480464	CTD
G	ABHD14B	abhydrolase domain containing 14B		affects expression	EXP	3	52,002,526	52,008,646	RGD:6480464	CTD
G	ACTA1	actin, alpha 1, skeletal muscle		affects expression	EXP	1	229,566,992	229,569,843	RGD:6480464	CTD
G	ACTA2	actin, alpha 2, smooth muscle, aorta		multiple interactions	ISO	10	90,694,831	90,751,147	RGD:6480464	CTD
G	ACTB	actin, beta		decreases expression	EXP	7	5,566,779	5,570,232	RGD:6480464	CTD
G	ACTL7A	actin-like 7A		affects expression	EXP	9	111,624,603	111,626,035	RGD:6480464	CTD
G	ACTR3	ARP3 actin-related protein 3 homolog (yeast)		affects expression	EXP	2	114,647,537	114,716,167	RGD:6480464	CTD
G	ACTR5	ARP5 actin-related protein 5 homolog (yeast)		affects expression	EXP	20	37,377,097	37,401,089	RGD:6480464	CTD
G	ACTR6	ARP6 actin-related protein 6 homolog (yeast)		affects expression	EXP	12	100,593,865	100,618,202	RGD:6480464	CTD
G	ACYP1	acylphosphatase 1, erythrocyte (common) type		affects expression	EXP	14	75,519,924	75,530,736	RGD:6480464	CTD
G	ADAM9	ADAM metallopeptidase domain 9		multiple interactions	EXP	8	38,854,505	38,962,780	RGD:6480464	CTD
G	ADAM9	ADAM metallopeptidase domain 9		multiple interactions	EXP	8	38,854,505	38,962,780	RGD:6480464	CTD
G	ADAM9	ADAM metallopeptidase domain 9		increases expression	EXP	8	38,854,505	38,962,780	RGD:6480464	CTD
G	ADAMTS19	ADAM metallopeptidase with thrombospondin type 1 motif, 19		affects expression	EXP	5	128,796,103	129,074,376	RGD:6480464	CTD
G	ADCK1	aarF domain containing kinase 1		affects expression	EXP	14	78,266,426	78,400,297	RGD:6480464	CTD
G	ADCK5	aarF domain containing kinase 5		affects expression	EXP	8	145,597,731	145,618,457	RGD:6480464	CTD
G	ADCY3	adenylate cyclase 3		decreases expression	EXP	2	25,042,038	25,142,055	RGD:6480464	CTD
G	ADH5	alcohol dehydrogenase 5 (class III), chi polypeptide		affects expression	EXP	4	99,992,129	100,009,931	RGD:6480464	CTD
G	ADH7	alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide		increases expression	ISO	4	100,333,418	100,356,667	RGD:6480464	CTD
G	ADI1	acireductone dioxygenase 1		affects expression	EXP	2	3,501,690	3,523,350	RGD:6480464	CTD
G	ADM	adrenomedullin		affects expression	EXP	11	10,326,642	10,328,923	RGD:6480464	CTD
G	ADM	adrenomedullin		increases expression	EXP	11	10,326,642	10,328,923	RGD:6480464	CTD
G	ADORA1	adenosine A1 receptor		decreases expression	EXP	1	203,096,836	203,136,533	RGD:6480464	CTD
G	ADSS	adenylosuccinate synthase		affects expression	EXP	1	244,571,794	244,615,436	RGD:6480464	CTD
G	ADSSL1	adenylosuccinate synthase like 1		affects expression	EXP	14	105,190,534	105,213,647	RGD:6480464	CTD
G	AFF1	AF4/FMR2 family, member 1		affects expression	EXP	4	87,856,154	88,062,206	RGD:6480464	CTD
G	AFTPH	aftiphilin		affects expression	EXP	2	64,751,439	64,820,139	RGD:6480464	CTD
G	AGFG2	ArfGAP with FG repeats 2		affects expression	EXP	7	100,136,834	100,165,843	RGD:6480464	CTD
G	AGR2	anterior gradient 2 homolog (Xenopus laevis)		affects expression	EXP	7	16,832,264	16,844,738	RGD:6480464	CTD
G	AGR3	anterior gradient 3 homolog (Xenopus laevis)		affects expression	EXP	7	16,899,030	16,921,613	RGD:6480464	CTD
G	AGT	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		increases abundance	ISO	1	230,838,269	230,850,336	RGD:6480464	CTD
G	AGT	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	1	230,838,269	230,850,336	RGD:6480464	CTD
G	AGT	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		increases abundance	ISO	1	230,838,269	230,850,336	RGD:6480464	CTD
G	AGT	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		affects expression	EXP	1	230,838,269	230,850,336	RGD:6480464	CTD
G	AGT	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		increases expression	ISO	1	230,838,269	230,850,336	RGD:6480464	CTD
G	AGT	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)		multiple interactions	ISO	1	230,838,269	230,850,336	RGD:6480464	CTD
G	AGXT2L2	alanine-glyoxylate aminotransferase 2-like 2		affects expression	EXP	5	177,635,540	177,659,803	RGD:6480464	CTD
G	AHR	aryl hydrocarbon receptor		affects expression	EXP	7	17,338,276	17,385,775	RGD:6480464	CTD
G	AHR	aryl hydrocarbon receptor		multiple interactions	ISO	7	17,338,276	17,385,775	RGD:6480464	CTD
G	AHR	aryl hydrocarbon receptor		decreases expression	ISO	7	17,338,276	17,385,775	RGD:6480464	CTD
G	AHSA1	AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast)		affects expression	EXP	14	77,924,373	77,935,815	RGD:6480464	CTD
G	AIFM2	apoptosis-inducing factor, mitochondrion-associated, 2		multiple interactions	ISO	10	71,872,023	71,892,690	RGD:6480464	CTD
G	AIFM2	apoptosis-inducing factor, mitochondrion-associated, 2		increases secretion	ISO	10	71,872,023	71,892,690	RGD:6480464	CTD
G	AIM1	absent in melanoma 1		affects expression	EXP	6	106,959,730	107,018,335	RGD:6480464	CTD
G	AIMP1	aminoacyl tRNA synthetase complex-interacting multifunctional protein 1		affects expression	EXP	4	107,236,767	107,270,382	RGD:6480464	CTD
G	AKAP7	A kinase (PRKA) anchor protein 7		affects expression	EXP	6	131,456,826	131,604,675	RGD:6480464	CTD
G	AKR1C1	aldo-keto reductase family 1, member C1		increases expression	EXP	10	5,005,454	5,020,158	RGD:6480464	CTD
G	AKR1C2	aldo-keto reductase family 1, member C2		increases expression	EXP	10	5,029,967	5,060,225	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases phosphorylation	EXP	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		increases phosphorylation	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		decreases phosphorylation	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	AKT1	v-akt murine thymoma viral oncogene homolog 1		multiple interactions	ISO	14	105,235,686	105,262,080	RGD:6480464	CTD
G	ALAD	aminolevulinate dehydratase		affects expression	EXP	9	116,148,592	116,163,618	RGD:6480464	CTD
G	ALB	albumin		multiple interactions	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALB	albumin		increases abundance	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALB	albumin		affects expression	EXP	4	74,269,972	74,287,129	RGD:6480464	CTD
G	ALDH1A1	aldehyde dehydrogenase 1 family, member A1		affects expression	EXP	9	75,515,578	75,568,233	RGD:6480464	CTD
G	ALDH1B1	aldehyde dehydrogenase 1 family, member B1		affects expression	EXP	9	38,392,661	38,398,662	RGD:6480464	CTD
G	ALDH6A1	aldehyde dehydrogenase 6 family, member A1		affects expression	EXP	14	74,526,869	74,551,196	RGD:6480464	CTD
G	ALG5	ALG5, dolichyl-phosphate beta-glucosyltransferase		affects expression	EXP	13	37,523,907	37,573,504	RGD:6480464	CTD
G	ALK	anaplastic lymphoma receptor tyrosine kinase		increases phosphorylation	EXP	2	29,415,640	30,144,477	RGD:6480464	CTD
G	ALMS1	Alstrom syndrome 1		affects expression	EXP	2	73,612,886	73,837,046	RGD:6480464	CTD
G	ALOX5	arachidonate 5-lipoxygenase		multiple interactions	EXP	10	45,869,624	45,941,567	RGD:6480464	CTD
G	ALOX5	arachidonate 5-lipoxygenase		increases activity	EXP	10	45,869,624	45,941,567	RGD:6480464	CTD
G	ALOX5	arachidonate 5-lipoxygenase		multiple interactions	EXP	10	45,869,624	45,941,567	RGD:6480464	CTD
G	ALOX5	arachidonate 5-lipoxygenase		multiple interactions	ISO	10	45,869,624	45,941,567	RGD:6480464	CTD
G	ALOX5	arachidonate 5-lipoxygenase		affects localization	ISO	10	45,869,624	45,941,567	RGD:6480464	CTD
G	ALOX5	arachidonate 5-lipoxygenase		multiple interactions	ISO	10	45,869,624	45,941,567	RGD:6480464	CTD
G	ALOX5	arachidonate 5-lipoxygenase		decreases activity	ISO	10	45,869,624	45,941,567	RGD:6480464	CTD
G	ALOX5AP	arachidonate 5-lipoxygenase-activating protein		increases expression	EXP	13	31,287,615	31,338,565	RGD:6480464	CTD
G	ALS2CR8	amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8		affects expression	EXP	2	203,776,978	203,851,060	RGD:6480464	CTD
G	AMD1	adenosylmethionine decarboxylase 1		affects expression	EXP	6	111,195,987	111,216,913	RGD:6480464	CTD
G	AMICA1	adhesion molecule, interacts with CXADR antigen 1		affects expression	EXP	11	118,064,442	118,095,809	RGD:6480464	CTD
G	AMOTL2	angiomotin like 2		affects expression	EXP	3	134,074,190	134,093,406	RGD:6480464	CTD
G	AMPH	amphiphysin		decreases expression	EXP	7	38,423,297	38,671,167	RGD:6480464	CTD
G	ANGPT1	angiopoietin 1		affects expression	EXP	8	108,261,710	108,510,254	RGD:6480464	CTD
G	ANKRD1	ankyrin repeat domain 1 (cardiac muscle)		affects expression	EXP	10	92,671,857	92,681,032	RGD:6480464	CTD
G	ANKRD16	ankyrin repeat domain 16		affects expression	EXP	10	5,903,689	5,931,860	RGD:6480464	CTD
G	ANLN	anillin, actin binding protein		affects expression	EXP	7	36,429,432	36,493,400	RGD:6480464	CTD
G	ANP32D	acidic (leucine-rich) nuclear phosphoprotein 32 family, member D		affects expression	EXP	12	48,866,448	48,866,843	RGD:6480464	CTD
G	ANXA13	annexin A13		affects expression	EXP	8	124,693,034	124,749,647	RGD:6480464	CTD
G	ANXA4	annexin A4		affects expression	EXP	2	69,969,127	70,053,596	RGD:6480464	CTD
G	AP1S3	adaptor-related protein complex 1, sigma 3 subunit		affects expression	EXP	2	224,620,047	224,702,319	RGD:6480464	CTD
G	APC	adenomatous polyposis coli		decreases expression	EXP	5	112,043,202	112,181,936	RGD:6480464	CTD
G	APEH	N-acylaminoacyl-peptide hydrolase		decreases response to substance	EXP	3	49,711,435	49,720,934	RGD:6480464	CTD
G	APEX1	APEX nuclease (multifunctional DNA repair enzyme) 1		increases response to substance	EXP	14	20,923,290	20,925,931	RGD:6480464	CTD
G	APH1B	anterior pharynx defective 1 homolog B (C. elegans)		affects expression	EXP	15	63,569,749	63,601,325	RGD:6480464	CTD
G	APOA4	apolipoprotein A-IV		affects expression	EXP	11	116,691,418	116,694,011	RGD:6480464	CTD
G	APOB	apolipoprotein B (including Ag(x) antigen)		affects expression	EXP	2	21,224,301	21,266,945	RGD:6480464	CTD
G	APOBEC2	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2		affects expression	EXP	6	41,020,940	41,032,630	RGD:6480464	CTD
G	APOBEC3F	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F		affects expression	EXP	22	39,436,673	39,451,977	RGD:6480464	CTD
G	APOC3	apolipoprotein C-III		affects expression	EXP	11	116,700,624	116,703,787	RGD:6480464	CTD
G	APOM	apolipoprotein M		affects expression	EXP	6	31,620,187	31,625,987	RGD:6480464	CTD
G	APP	amyloid beta (A4) precursor protein		multiple interactions	EXP	21	27,252,861	27,543,446	RGD:6480464	CTD
G	APP	amyloid beta (A4) precursor protein		increases expression	EXP	21	27,252,861	27,543,446	RGD:6480464	CTD
G	AQP1	aquaporin 1 (Colton blood group)		affects expression	EXP	7	30,951,415	30,965,131	RGD:6480464	CTD
G	AQP11	aquaporin 11		affects expression	EXP	11	77,300,680	77,321,401	RGD:6480464	CTD
G	AREG	amphiregulin		affects expression	EXP	4	75,310,853	75,320,726	RGD:6480464	CTD
G	AREG	amphiregulin		increases expression	EXP	4	75,310,853	75,320,726	RGD:6480464	CTD
G	ARG1	arginase, liver		affects expression	EXP	6	131,894,344	131,905,472	RGD:6480464	CTD
G	ARHGAP22	Rho GTPase activating protein 22		affects expression	EXP	10	49,654,068	49,864,310	RGD:6480464	CTD
G	ARHGAP29	Rho GTPase activating protein 29		affects expression	EXP	1	94,634,463	94,703,307	RGD:6480464	CTD
G	ARHGDIA	Rho GDP dissociation inhibitor (GDI) alpha		decreases expression	EXP	17	79,825,597	79,829,282	RGD:6480464	CTD
G	ARHGEF17	Rho guanine nucleotide exchange factor (GEF) 17		affects expression	EXP	11	73,019,663	73,080,425	RGD:6480464	CTD
G	ARL14	ADP-ribosylation factor-like 14		affects expression	EXP	3	160,394,948	160,396,236	RGD:6480464	CTD
G	ARL4C	ADP-ribosylation factor-like 4C		affects expression	EXP	2	235,401,685	235,405,693	RGD:6480464	CTD
G	ARL6IP5	ADP-ribosylation-like factor 6 interacting protein 5		multiple interactions	EXP	3	69,134,090	69,155,239	RGD:6480464	CTD
G	ARL8B	ADP-ribosylation factor-like 8B		affects expression	EXP	3	5,163,930	5,222,601	RGD:6480464	CTD
G	ARMCX3	armadillo repeat containing, X-linked 3		affects expression	EXP	X	100,878,120	100,882,831	RGD:6480464	CTD
G	ARNT	aryl hydrocarbon receptor nuclear translocator		multiple interactions	EXP	1	150,782,181	150,849,244	RGD:6480464	CTD
G	ARNT	aryl hydrocarbon receptor nuclear translocator		increases expression	EXP	1	150,782,181	150,849,244	RGD:6480464	CTD
G	ARNT	aryl hydrocarbon receptor nuclear translocator		decreases expression	EXP	1	150,782,181	150,849,244	RGD:6480464	CTD
G	ATP5B	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide		affects expression	EXP	12	57,031,959	57,039,852	RGD:6480464	CTD
G	ATP5F1	ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1		affects expression	EXP	1	111,991,743	112,004,540	RGD:6480464	CTD
G	ATP6V1D	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D		affects expression	EXP	14	67,804,581	67,826,720	RGD:6480464	CTD
G	ATP7B	ATPase, Cu++ transporting, beta polypeptide		affects expression	EXP	13	52,506,805	52,585,630	RGD:6480464	CTD
G	ATP8B3	ATPase, aminophospholipid transporter, class I, type 8B, member 3		affects expression	EXP	19	1,782,074	1,812,275	RGD:6480464	CTD
G	ATXN1	ataxin 1		multiple interactions	EXP	6	16,299,343	16,761,721	RGD:6480464	CTD
G	ATXN1	ataxin 1		affects localization	EXP	6	16,299,343	16,761,721	RGD:6480464	CTD
G	AURKB	aurora kinase B		decreases expression	EXP	17	8,108,049	8,113,944	RGD:6480464	CTD
G	AXL	AXL receptor tyrosine kinase		multiple interactions	ISO	19	41,725,108	41,767,671	RGD:6480464	CTD
G	AXL	AXL receptor tyrosine kinase		multiple interactions	ISO	19	41,725,108	41,767,671	RGD:6480464	CTD
G	AXL	AXL receptor tyrosine kinase		increases phosphorylation	ISO	19	41,725,108	41,767,671	RGD:6480464	CTD
G	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3		affects expression	EXP	19	17,905,919	17,924,385	RGD:6480464	CTD
G	B3GNT5	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5		affects expression	EXP	3	182,971,032	182,991,179	RGD:6480464	CTD
G	BAD	BCL2-associated agonist of cell death		increases expression	ISO	11	64,037,300	64,052,176	RGD:6480464	CTD
G	BAG2	BCL2-associated athanogene 2		affects expression	EXP	6	57,037,104	57,050,013	RGD:6480464	CTD
G	BAHCC1	BAH domain and coiled-coil containing 1		affects expression	EXP	17	79,373,540	79,433,358	RGD:6480464	CTD
G	BAK1	BCL2-antagonist/killer 1		decreases expression	EXP	6	33,540,323	33,548,070	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		decreases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases activity	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	EXP	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		affects expression	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		increases expression	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		affects expression	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAX	BCL2-associated X protein		multiple interactions	ISO	19	49,458,117	49,465,055	RGD:6480464	CTD
G	BAZ2A	bromodomain adjacent to zinc finger domain, 2A		affects expression	EXP	12	56,989,380	57,030,163	RGD:6480464	CTD
G	BBC3	BCL2 binding component 3		affects expression	EXP	19	47,724,079	47,736,023	RGD:6480464	CTD
G	BCAR1	breast cancer anti-estrogen resistance 1		affects expression	EXP	16	75,262,928	75,301,951	RGD:6480464	CTD
G	BCKDK	branched chain ketoacid dehydrogenase kinase		affects expression	EXP	16	31,119,662	31,124,112	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases response to substance	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		increases expression	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	EXP	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		affects response to substance	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		affects expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		decreases expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		increases expression	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2	B-cell CLL/lymphoma 2		multiple interactions	ISO	18	60,790,579	60,986,613	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		increases expression	ISO	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L1	BCL2-like 1		decreases response to substance	ISO	20	30,252,261	30,310,656	RGD:6480464	CTD
G	BCL2L14	BCL2-like 14 (apoptosis facilitator)		affects expression	EXP	12	12,223,878	12,252,629	RGD:6480464	CTD
G	BCL3	B-cell CLL/lymphoma 3		affects expression	EXP	19	45,251,978	45,263,301	RGD:6480464	CTD
G	BCL6	B-cell CLL/lymphoma 6		affects expression	EXP	3	187,439,165	187,463,513	RGD:6480464	CTD
G	BCLAF1	BCL2-associated transcription factor 1		affects expression	EXP	6	136,578,001	136,610,989	RGD:6480464	CTD
G	BCORL1	BCL6 corepressor-like 1		affects expression	EXP	X	129,139,164	129,192,058	RGD:6480464	CTD
G	BDH2	3-hydroxybutyrate dehydrogenase, type 2		affects expression	EXP	4	103,998,782	104,021,024	RGD:6480464	CTD
G	BECN1	beclin 1, autophagy related		multiple interactions	EXP	17	40,962,150	40,976,310	RGD:6480464	CTD
G	BECN1	beclin 1, autophagy related		increases expression	EXP	17	40,962,150	40,976,310	RGD:6480464	CTD
G	BFSP1	beaded filament structural protein 1, filensin		affects expression	EXP	20	17,474,550	17,539,605	RGD:6480464	CTD
G	BID	BH3 interacting domain death agonist		increases expression	ISO	22	18,216,906	18,257,431	RGD:6480464	CTD
G	BIN1	bridging integrator 1		multiple interactions	EXP	2	127,805,599	127,864,903	RGD:6480464	CTD
G	BIN1	bridging integrator 1		affects expression	EXP	2	127,805,599	127,864,903	RGD:6480464	CTD
G	BIRC5	baculoviral IAP repeat containing 5		affects expression	EXP	17	76,210,277	76,221,716	RGD:6480464	CTD
G	BLM	Bloom syndrome, RecQ helicase-like		affects expression	EXP	15	91,260,579	91,358,686	RGD:6480464	CTD
G	BLNK	B-cell linker		increases expression	ISO	10	97,951,455	98,031,333	RGD:6480464	CTD
G	BMP4	bone morphogenetic protein 4		decreases expression	EXP	14	54,416,454	54,423,554	RGD:6480464	CTD
G	BNIP3	BCL2/adenovirus E1B 19kDa interacting protein 3		affects expression	EXP	10	133,781,204	133,795,435	RGD:6480464	CTD
G	BNIP3	BCL2/adenovirus E1B 19kDa interacting protein 3		decreases expression	EXP	10	133,781,204	133,795,435	RGD:6480464	CTD
G	BNIP3L	BCL2/adenovirus E1B 19kDa interacting protein 3-like		affects expression	EXP	8	26,240,523	26,270,644	RGD:6480464	CTD
G	BOK	BCL2-related ovarian killer		affects expression	EXP	2	242,498,146	242,513,553	RGD:6480464	CTD
G	BRCA1	breast cancer 1, early onset		decreases response to substance	EXP	17	41,196,312	41,277,500	RGD:6480464	CTD
G	BRD8	bromodomain containing 8		affects expression	EXP	5	137,475,459	137,514,358	RGD:6480464	CTD
G	BSDC1	BSD domain containing 1		affects expression	EXP	1	32,830,704	32,860,062	RGD:6480464	CTD
G	BTG2	BTG family, member 2		affects expression	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BTG2	BTG family, member 2		increases expression	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BTG2	BTG family, member 2		increases expression	EXP	1	203,274,664	203,278,730	RGD:6480464	CTD
G	BTN2A2	butyrophilin, subfamily 2, member A2		affects expression	EXP	6	26,383,324	26,395,102	RGD:6480464	CTD
G	C11orf52	chromosome 11 open reading frame 52		affects expression	EXP	11	111,789,601	111,797,595	RGD:6480464	CTD
G	C11orf57	chromosome 11 open reading frame 57		affects expression	EXP	11	111,944,968	111,955,874	RGD:6480464	CTD
G	C11orf68	chromosome 11 open reading frame 68		affects expression	EXP	11	65,684,281	65,686,531	RGD:6480464	CTD
G	C11orf93	chromosome 11 open reading frame 93		affects expression	EXP	11	111,169,271	111,179,460	RGD:6480464	CTD
G	C12orf5	chromosome 12 open reading frame 5		affects expression	EXP	12	4,430,359	4,469,194	RGD:6480464	CTD
G	C12orf60	chromosome 12 open reading frame 60		affects expression	EXP	12	14,956,506	14,976,792	RGD:6480464	CTD
G	C12orf65	chromosome 12 open reading frame 65		affects expression	EXP	12	123,717,844	123,742,506	RGD:6480464	CTD
G	C14orf1	chromosome 14 open reading frame 1		affects expression	EXP	14	76,117,233	76,127,538	RGD:6480464	CTD
G	C14orf169	chromosome 14 open reading frame 169		affects expression	EXP	14	73,957,644	73,960,105	RGD:6480464	CTD
G	C14orf93	chromosome 14 open reading frame 93		affects expression	EXP	14	23,456,110	23,479,360	RGD:6480464	CTD
G	C19orf33	chromosome 19 open reading frame 33		affects expression	EXP	19	38,794,804	38,795,646	RGD:6480464	CTD
G	C19orf68	chromosome 19 open reading frame 68		affects expression	EXP	19	48,675,210	48,700,516	RGD:6480464	CTD
G	C1orf106	chromosome 1 open reading frame 106		affects expression	EXP	1	200,860,627	200,884,864	RGD:6480464	CTD
G	C1orf116	chromosome 1 open reading frame 116		affects expression	EXP	1	207,191,866	207,206,101	RGD:6480464	CTD
G	C1orf131	chromosome 1 open reading frame 131		affects expression	EXP	1	231,359,509	231,376,924	RGD:6480464	CTD
G	C1QBP	complement component 1, q subcomponent binding protein		affects expression	EXP	17	5,336,099	5,342,471	RGD:6480464	CTD
G	C1QTNF3	C1q and tumor necrosis factor related protein 3		affects expression	EXP	5	34,017,963	34,043,371	RGD:6480464	CTD
G	C20orf24	chromosome 20 open reading frame 24		affects expression	EXP	20	35,234,137	35,240,960	RGD:6480464	CTD
G	C2orf43	chromosome 2 open reading frame 43		affects expression	EXP	2	20,884,818	21,022,827	RGD:6480464	CTD
G	C2orf47	chromosome 2 open reading frame 47		affects expression	EXP	2	200,820,040	200,828,848	RGD:6480464	CTD
G	C3orf18	chromosome 3 open reading frame 18		affects expression	EXP	3	50,595,456	50,608,458	RGD:6480464	CTD
G	C3orf33	chromosome 3 open reading frame 33		affects expression	EXP	3	155,480,401	155,524,055	RGD:6480464	CTD
G	C5orf45	chromosome 5 open reading frame 45		affects expression	EXP	5	179,264,266	179,285,840	RGD:6480464	CTD
G	C6orf1	chromosome 6 open reading frame 1		affects expression	EXP	6	34,214,157	34,216,904	RGD:6480464	CTD
G	C6orf211	chromosome 6 open reading frame 211		affects expression	EXP	6	151,773,422	151,791,232	RGD:6480464	CTD
G	C6orf48	chromosome 6 open reading frame 48		affects expression	EXP	6	31,802,693	31,807,541	RGD:6480464	CTD
G	CAPN2	calpain 2, (m/II) large subunit		multiple interactions	ISO	1	223,889,295	223,963,720	RGD:6480464	CTD
G	CAPNS1	calpain, small subunit 1		decreases expression	EXP	19	36,630,918	36,641,255	RGD:6480464	CTD
G	CAPNS2	calpain, small subunit 2		affects expression	EXP	16	55,600,584	55,601,592	RGD:6480464	CTD
G	CAPS	calcyphosine		affects expression	EXP	19	5,914,193	5,916,222	RGD:6480464	CTD
G	CARD10	caspase recruitment domain family, member 10		affects expression	EXP	22	37,886,400	37,915,210	RGD:6480464	CTD
G	CARHSP1	calcium regulated heat stable protein 1, 24kDa		affects expression	EXP	16	8,946,802	8,962,863	RGD:6480464	CTD
G	CASK	calcium/calmodulin-dependent serine protein kinase (MAGUK family)		decreases expression	EXP	X	41,374,187	41,782,287	RGD:6480464	CTD
G	CASP1	caspase 1, apoptosis-related cysteine peptidase		increases activity	ISO	11	104,896,235	104,905,884	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		affects expression	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases activity	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	EXP	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases activity	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases cleavage	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		decreases expression	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		increases activity	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP3	caspase 3, apoptosis-related cysteine peptidase		multiple interactions	ISO	4	185,548,850	185,570,629	RGD:6480464	CTD
G	CASP4	caspase 4, apoptosis-related cysteine peptidase		affects expression	EXP	11	104,813,594	104,839,325	RGD:6480464	CTD
G	CASP6	caspase 6, apoptosis-related cysteine peptidase		affects expression	EXP	4	110,609,785	110,624,629	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		increases activity	ISO	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP7	caspase 7, apoptosis-related cysteine peptidase		multiple interactions	ISO	10	115,438,921	115,490,668	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases activity	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	EXP	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		multiple interactions	ISO	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP8	caspase 8, apoptosis-related cysteine peptidase		increases activity	ISO	2	202,098,166	202,152,434	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		increases activity	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	EXP	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		increases cleavage	ISO	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CASP9	caspase 9, apoptosis-related cysteine peptidase		multiple interactions	ISO	1	15,818,769	15,851,285	RGD:6480464	CTD
G	CAST	calpastatin		affects expression	EXP	5	95,997,741	96,110,387	RGD:6480464	CTD
G	CAT	catalase		affects response to substance	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases response to substance	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		increases activity	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		affects expression	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		increases expression	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		increases expression	EXP	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		affects response to substance	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases activity	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		decreases expression	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		increases activity	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		increases expression	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		increases activity	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		increases expression	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAT	catalase		multiple interactions	ISO	11	34,460,472	34,493,607	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		multiple interactions	EXP	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		increases expression	EXP	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		multiple interactions	EXP	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		multiple interactions	ISO	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		multiple interactions	EXP	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		increases expression	ISO	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		increases expression	ISO	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		multiple interactions	ISO	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CAV1	caveolin 1, caveolae protein, 22kDa		multiple interactions	ISO	7	116,164,839	116,201,239	RGD:6480464	CTD
G	CBFB	core-binding factor, beta subunit		affects expression	EXP	16	67,063,050	67,134,961	RGD:6480464	CTD
G	CBLB	Cbl proto-oncogene, E3 ubiquitin protein ligase B		affects expression	EXP	3	105,377,109	105,587,887	RGD:6480464	CTD
G	CBX7	chromobox homolog 7		affects expression	EXP	22	39,526,777	39,548,538	RGD:6480464	CTD
G	CCDC150	coiled-coil domain containing 150		affects expression	EXP	2	197,504,356	197,597,530	RGD:6480464	CTD
G	CCDC28A	coiled-coil domain containing 28A		affects expression	EXP	6	139,094,657	139,114,456	RGD:6480464	CTD
G	CCDC86	coiled-coil domain containing 86		affects expression	EXP	11	60,609,429	60,618,561	RGD:6480464	CTD
G	CCK	cholecystokinin		affects expression	EXP	3	42,299,318	42,307,662	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		increases expression	EXP	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		multiple interactions	EXP	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		increases expression	EXP	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCL2	chemokine (C-C motif) ligand 2		multiple interactions	EXP	17	32,582,296	32,584,222	RGD:6480464	CTD
G	CCNA1	cyclin A1		decreases expression	EXP	13	37,005,967	37,017,019	RGD:6480464	CTD
G	CCNA2	cyclin A2		decreases expression	EXP	4	122,737,599	122,745,088	RGD:6480464	CTD
G	CCNB1	cyclin B1		affects expression	EXP	5	68,462,837	68,474,072	RGD:6480464	CTD
G	CCNB2	cyclin B2		affects expression	EXP	15	59,397,284	59,417,244	RGD:6480464	CTD
G	CD59	CD59 molecule, complement regulatory protein		increases mutagenesis	EXP	11	33,724,556	33,758,025	RGD:6480464	CTD
G	CD68	CD68 molecule		increases expression	ISO	17	7,482,805	7,485,429	RGD:6480464	CTD
G	CD97	CD97 molecule		affects expression	EXP	19	14,491,956	14,519,537	RGD:6480464	CTD
G	CDA	cytidine deaminase		affects expression	EXP	1	20,915,444	20,945,401	RGD:6480464	CTD
G	CDC16	cell division cycle 16		affects expression	EXP	13	115,000,362	115,038,150	RGD:6480464	CTD
G	CDC20	cell division cycle 20		decreases expression	EXP	1	43,824,626	43,828,874	RGD:6480464	CTD
G	CDC25A	cell division cycle 25A		affects expression	EXP	3	48,198,668	48,229,801	RGD:6480464	CTD
G	CDC25A	cell division cycle 25A		decreases expression	EXP	3	48,198,668	48,229,801	RGD:6480464	CTD
G	CDC25C	cell division cycle 25C		affects expression	EXP	5	137,620,959	137,667,516	RGD:6480464	CTD
G	CDC25C	cell division cycle 25C		decreases expression	EXP	5	137,620,959	137,667,516	RGD:6480464	CTD
G	CDC25C	cell division cycle 25C		increases expression	ISO	5	137,620,959	137,667,516	RGD:6480464	CTD
G	CDC42EP2	CDC42 effector protein (Rho GTPase binding) 2		affects expression	EXP	11	65,082,289	65,089,900	RGD:6480464	CTD
G	CDC5L	cell division cycle 5-like		affects expression	EXP	6	44,355,251	44,418,161	RGD:6480464	CTD
G	CDCA2	cell division cycle associated 2		affects expression	EXP	8	25,316,513	25,365,425	RGD:6480464	CTD
G	CDH11	cadherin 11, type 2, OB-cadherin (osteoblast)		decreases expression	EXP	16	64,980,683	65,155,919	RGD:6480464	CTD
G	CDH2	cadherin 2, type 1, N-cadherin (neuronal)		decreases expression	EXP	18	25,530,930	25,757,445	RGD:6480464	CTD
G	CDH3	cadherin 3, type 1, P-cadherin (placental)		decreases expression	EXP	16	68,678,151	68,732,957	RGD:6480464	CTD
G	CDK1	cyclin-dependent kinase 1		affects expression	EXP	10	62,538,089	62,554,610	RGD:6480464	CTD
G	CDK10	cyclin-dependent kinase 10		decreases expression	EXP	16	89,753,076	89,762,772	RGD:6480464	CTD
G	CDK2	cyclin-dependent kinase 2		decreases expression	EXP	12	56,360,556	56,366,568	RGD:6480464	CTD
G	CDK2	cyclin-dependent kinase 2		decreases activity	EXP	12	56,360,556	56,366,568	RGD:6480464	CTD
G	CDK5	cyclin-dependent kinase 5		affects expression	EXP	7	150,750,899	150,755,052	RGD:6480464	CTD
G	CDK5RAP3	CDK5 regulatory subunit associated protein 3		affects expression	EXP	17	46,048,429	46,059,147	RGD:6480464	CTD
G	CDK9	cyclin-dependent kinase 9		decreases expression	EXP	9	130,548,305	130,553,052	RGD:6480464	CTD
G	CDKL3	cyclin-dependent kinase-like 3		affects expression	EXP	5	133,634,115	133,702,765	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	EXP	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		increases expression	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1A	cyclin-dependent kinase inhibitor 1A (p21, Cip1)		multiple interactions	ISO	6	36,644,237	36,655,116	RGD:6480464	CTD
G	CDKN1C	cyclin-dependent kinase inhibitor 1C (p57, Kip2)		affects expression	EXP	11	2,904,448	2,906,995	RGD:6480464	CTD
G	CDKN2B	cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)		decreases expression	EXP	9	22,002,902	22,009,312	RGD:6480464	CTD
G	CDKN2B	cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)		decreases expression	ISO	9	22,002,902	22,009,312	RGD:6480464	CTD
G	CDKN2D	cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)		affects expression	EXP	19	10,677,138	10,679,655	RGD:6480464	CTD
G	CDKN2D	cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)		decreases expression	EXP	19	10,677,138	10,679,655	RGD:6480464	CTD
G	CDRT4	CMT1A duplicated region transcript 4		affects expression	EXP	17	15,339,332	15,370,925	RGD:6480464	CTD
G	CDX2	caudal type homeobox 2		affects expression	EXP	13	28,536,205	28,543,505	RGD:6480464	CTD
G	CEACAM1	carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)		affects expression	EXP	19	43,011,458	43,032,661	RGD:6480464	CTD
G	CEACAM5	carcinoembryonic antigen-related cell adhesion molecule 5		affects expression	EXP	19	42,212,530	42,234,437	RGD:6480464	CTD
G	CEBPB	CCAAT/enhancer binding protein (C/EBP), beta		affects expression	EXP	20	48,807,120	48,809,227	RGD:6480464	CTD
G	CEBPD	CCAAT/enhancer binding protein (C/EBP), delta		affects expression	EXP	8	48,649,476	48,650,726	RGD:6480464	CTD
G	CEBPG	CCAAT/enhancer binding protein (C/EBP), gamma		affects expression	EXP	19	33,864,575	33,873,592	RGD:6480464	CTD
G	CENPA	centromere protein A		decreases expression	EXP	2	27,008,882	27,017,457	RGD:6480464	CTD
G	CENPF	centromere protein F, 350/400kDa		affects expression	EXP	1	214,776,532	214,837,914	RGD:6480464	CTD
G	CENPH	centromere protein H		affects expression	EXP	5	68,485,375	68,506,184	RGD:6480464	CTD
G	CEP120	centrosomal protein 120kDa		affects expression	EXP	5	122,680,579	122,759,286	RGD:6480464	CTD
G	CETN2	centrin, EF-hand protein, 2		affects expression	EXP	X	151,995,871	151,999,301	RGD:6480464	CTD
G	CFLAR	CASP8 and FADD-like apoptosis regulator		increases expression	EXP	2	201,980,877	202,037,411	RGD:6480464	CTD
G	CFLAR	CASP8 and FADD-like apoptosis regulator		decreases expression	ISO	2	201,980,877	202,037,411	RGD:6480464	CTD
G	CFTR	cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)		affects expression	EXP	7	117,120,017	117,308,719	RGD:6480464	CTD
G	CGREF1	cell growth regulator with EF-hand domain 1		affects expression	EXP	2	27,322,221	27,341,995	RGD:6480464	CTD
G	CHD4	chromodomain helicase DNA binding protein 4		affects expression	EXP	12	6,679,248	6,716,551	RGD:6480464	CTD
G	CHEK1	checkpoint kinase 1		decreases expression	EXP	11	125,495,031	125,546,150	RGD:6480464	CTD
G	CHSY1	chondroitin sulfate synthase 1		affects expression	EXP	15	101,715,928	101,792,137	RGD:6480464	CTD
G	CIRH1A	cirrhosis, autosomal recessive 1A (cirhin)		affects expression	EXP	16	69,166,499	69,202,937	RGD:6480464	CTD
G	CISH	cytokine inducible SH2-containing protein		affects expression	EXP	3	50,643,885	50,649,262	RGD:6480464	CTD
G	CITED2	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2		affects expression	EXP	6	139,693,392	139,695,787	RGD:6480464	CTD
G	CKB	creatine kinase, brain		affects expression	EXP	14	103,985,995	103,989,196	RGD:6480464	CTD
G	CKM	creatine kinase, muscle		multiple interactions	ISO	19	45,809,671	45,826,235	RGD:6480464	CTD
G	CKM	creatine kinase, muscle		decreases expression	ISO	19	45,809,671	45,826,235	RGD:6480464	CTD
G	CLCF1	cardiotrophin-like cytokine factor 1		affects expression	EXP	11	67,131,639	67,141,648	RGD:6480464	CTD
G	CLDN1	claudin 1		affects expression	EXP	3	190,023,490	190,040,235	RGD:6480464	CTD
G	CLDN2	claudin 2		affects expression	EXP	X	106,143,394	106,174,091	RGD:6480464	CTD
G	CLDN23	claudin 23		affects expression	EXP	8	8,559,666	8,561,617	RGD:6480464	CTD
G	CLDN3	claudin 3		affects expression	EXP	7	73,183,327	73,184,600	RGD:6480464	CTD
G	CLDN6	claudin 6		multiple interactions	EXP	16	3,064,713	3,068,188	RGD:6480464	CTD
G	CLDN6	claudin 6		affects expression	EXP	16	3,064,713	3,068,188	RGD:6480464	CTD
G	CLDN7	claudin 7		affects expression	EXP	17	7,163,222	7,166,512	RGD:6480464	CTD
G	CLDN8	claudin 8		affects expression	EXP	21	31,586,324	31,588,469	RGD:6480464	CTD
G	CLDN9	claudin 9		multiple interactions	EXP	16	3,062,457	3,064,506	RGD:6480464	CTD
G	CLDN9	claudin 9		affects expression	EXP	16	3,062,457	3,064,506	RGD:6480464	CTD
G	CLDND1	claudin domain containing 1		affects expression	EXP	3	98,234,317	98,241,910	RGD:6480464	CTD
G	CLIC5	chloride intracellular channel 5		affects expression	EXP	6	45,866,188	46,048,085	RGD:6480464	CTD
G	CLMP	CXADR-like membrane protein		affects expression	EXP	11	122,943,020	123,066,007	RGD:6480464	CTD
G	CLPTM1L	CLPTM1-like		affects expression	EXP	5	1,317,999	1,345,002	RGD:6480464	CTD
G	CMTM6	CKLF-like MARVEL transmembrane domain containing 6		affects expression	EXP	3	32,522,804	32,544,403	RGD:6480464	CTD
G	CNKSR3	CNKSR family member 3		affects expression	EXP	6	154,726,433	154,831,753	RGD:6480464	CTD
G	CNNM2	cyclin M2		affects expression	EXP	10	104,678,075	104,838,344	RGD:6480464	CTD
G	CNOT2	CCR4-NOT transcription complex, subunit 2		affects expression	EXP	12	70,636,774	70,748,773	RGD:6480464	CTD
G	CNTF	ciliary neurotrophic factor		multiple interactions	EXP	11	58,390,146	58,393,206	RGD:6480464	CTD
G	CNTF	ciliary neurotrophic factor		decreases activity	EXP	11	58,390,146	58,393,206	RGD:6480464	CTD
G	CNTF	ciliary neurotrophic factor		multiple interactions	ISO	11	58,390,146	58,393,206	RGD:6480464	CTD
G	COG6	component of oligomeric golgi complex 6		affects expression	EXP	13	40,229,764	40,365,802	RGD:6480464	CTD
G	COL16A1	collagen, type XVI, alpha 1		affects expression	EXP	1	32,117,848	32,169,768	RGD:6480464	CTD
G	COL18A1	collagen, type XVIII, alpha 1		affects expression	EXP	21	46,825,097	46,933,634	RGD:6480464	CTD
G	COL1A1	collagen, type I, alpha 1		multiple interactions	ISO	17	48,261,457	48,279,000	RGD:6480464	CTD
G	COL4A6	collagen, type IV, alpha 6		affects expression	EXP	X	107,398,837	107,682,704	RGD:6480464	CTD
G	COL9A3	collagen, type IX, alpha 3		affects expression	EXP	20	61,448,414	61,472,511	RGD:6480464	CTD
G	COMMD8	COMM domain containing 8		affects expression	EXP	4	47,452,815	47,465,676	RGD:6480464	CTD
G	COMT	catechol-O-methyltransferase		decreases expression	EXP	22	19,929,263	19,957,498	RGD:6480464	CTD
G	COPB2	coatomer protein complex, subunit beta 2 (beta prime)		affects expression	EXP	3	139,076,433	139,108,522	RGD:6480464	CTD
G	COPS5	COP9 signalosome subunit 5		affects expression	EXP	8	67,955,314	67,974,562	RGD:6480464	CTD
G	COPS8	COP9 signalosome subunit 8		affects expression	EXP	2	237,994,084	238,007,489	RGD:6480464	CTD
G	COQ5	coenzyme Q5 homolog, methyltransferase (S. cerevisiae)		affects expression	EXP	12	120,941,082	120,966,964	RGD:6480464	CTD
G	CORO2A	coronin, actin binding protein, 2A		affects expression	EXP	9	100,883,257	100,954,956	RGD:6480464	CTD
G	CP	ceruloplasmin (ferroxidase)		multiple interactions	EXP	3	148,880,197	148,939,832	RGD:6480464	CTD
G	CP	ceruloplasmin (ferroxidase)		decreases expression	EXP	3	148,880,197	148,939,832	RGD:6480464	CTD
G	CP	ceruloplasmin (ferroxidase)		increases degradation	EXP	3	148,880,197	148,939,832	RGD:6480464	CTD
G	CP	ceruloplasmin (ferroxidase)		decreases expression	ISO	3	148,880,197	148,939,832	RGD:6480464	CTD
G	CPEB3	cytoplasmic polyadenylation element binding protein 3		affects expression	EXP	10	93,808,397	94,050,875	RGD:6480464	CTD
G	CPS1	carbamoyl-phosphate synthase 1, mitochondrial		affects expression	EXP	2	211,342,406	211,543,831	RGD:6480464	CTD
G	CPSF2	cleavage and polyadenylation specific factor 2, 100kDa		affects expression	EXP	14	92,588,298	92,630,543	RGD:6480464	CTD
G	CREB3L3	cAMP responsive element binding protein 3-like 3		affects expression	EXP	19	4,153,629	4,173,048	RGD:6480464	CTD
G	CREB3L4	cAMP responsive element binding protein 3-like 4		affects expression	EXP	1	153,940,315	153,946,840	RGD:6480464	CTD
G	CREBRF	CREB3 regulatory factor		affects expression	EXP	5	172,483,355	172,566,291	RGD:6480464	CTD
G	CRHR1	corticotropin releasing hormone receptor 1		decreases expression	EXP	17	43,697,710	43,913,194	RGD:6480464	CTD
G	CRIP1	cysteine-rich protein 1 (intestinal)		affects expression	EXP	14	105,953,257	105,955,126	RGD:6480464	CTD
G	CRYL1	crystallin, lambda 1		affects expression	EXP	13	20,977,806	21,100,012	RGD:6480464	CTD
G	CRYM	crystallin, mu		affects expression	EXP	16	21,269,839	21,314,404	RGD:6480464	CTD
G	CRYZ	crystallin, zeta (quinone reductase)		affects expression	EXP	1	75,171,170	75,199,092	RGD:6480464	CTD
G	CSDE1	cold shock domain containing E1, RNA-binding		affects expression	EXP	1	115,259,534	115,300,671	RGD:6480464	CTD
G	CSF1R	colony stimulating factor 1 receptor		affects expression	EXP	5	149,432,854	149,492,935	RGD:6480464	CTD
G	CSGALNACT1	chondroitin sulfate N-acetylgalactosaminyltransferase 1		affects expression	EXP	8	19,261,672	19,540,261	RGD:6480464	CTD
G	CSH1	chorionic somatomammotropin hormone 1 (placental lactogen)		affects expression	EXP	17	61,972,268	61,974,021	RGD:6480464	CTD
G	CSNK1G2	casein kinase 1, gamma 2		decreases expression	EXP	19	1,941,161	1,981,337	RGD:6480464	CTD
G	CSPP1	centrosome and spindle pole associated protein 1		affects expression	EXP	8	67,976,603	68,108,849	RGD:6480464	CTD
G	CXCL12	chemokine (C-X-C motif) ligand 12		increases expression	ISO	10	44,865,605	44,880,545	RGD:6480464	CTD
G	CXCL12	chemokine (C-X-C motif) ligand 12		multiple interactions	ISO	10	44,865,605	44,880,545	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		affects expression	EXP	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		increases expression	ISO	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCL2	chemokine (C-X-C motif) ligand 2		multiple interactions	ISO	4	74,962,752	74,964,997	RGD:6480464	CTD
G	CXCR4	chemokine (C-X-C motif) receptor 4		affects expression	EXP	2	136,871,919	136,875,725	RGD:6480464	CTD
G	CXorf45	chromosome X open reading frame 45		affects expression	EXP				RGD:6480464	CTD
G	CYB5A	cytochrome b5 type A (microsomal)		affects expression	EXP	18	71,920,527	71,959,251	RGD:6480464	CTD
G	CYB5B	cytochrome b5 type B (outer mitochondrial membrane)		affects expression	EXP	16	69,458,498	69,500,167	RGD:6480464	CTD
G	CYB5D2	cytochrome b5 domain containing 2		affects expression	EXP	17	4,046,462	4,060,995	RGD:6480464	CTD
G	CYGB	cytoglobin		increases metabolic processing	ISO	17	74,523,430	74,533,987	RGD:6480464	CTD
G	CYP1A1	cytochrome P450, family 1, subfamily A, polypeptide 1		affects expression	EXP	15	75,011,883	75,017,877	RGD:6480464	CTD
G	CYP1A1	cytochrome P450, family 1, subfamily A, polypeptide 1		increases expression	EXP	15	75,011,883	75,017,877	RGD:6480464	CTD
G	CYP1A1	cytochrome P450, family 1, subfamily A, polypeptide 1		multiple interactions	EXP	15	75,011,883	75,017,877	RGD:6480464	CTD
G	CYP1A1	cytochrome P450, family 1, subfamily A, polypeptide 1		increases expression	ISO	15	75,011,883	75,017,877	RGD:6480464	CTD
G	CYP1B1	cytochrome P450, family 1, subfamily B, polypeptide 1		affects expression	EXP	2	38,294,746	38,303,323	RGD:6480464	CTD
G	CYP1B1	cytochrome P450, family 1, subfamily B, polypeptide 1		increases expression	EXP	2	38,294,746	38,303,323	RGD:6480464	CTD
G	CYP2S1	cytochrome P450, family 2, subfamily S, polypeptide 1		multiple interactions	EXP	19	41,699,115	41,713,444	RGD:6480464	CTD
G	CYP2W1	cytochrome P450, family 2, subfamily W, polypeptide 1		affects expression	EXP	7	1,022,835	1,029,276	RGD:6480464	CTD
G	CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4		increases expression	EXP	7	99,354,583	99,381,811	RGD:6480464	CTD
G	CYP51A1	cytochrome P450, family 51, subfamily A, polypeptide 1		multiple interactions	EXP	7	91,741,463	91,764,059	RGD:6480464	CTD
G	CYR61	cysteine-rich, angiogenic inducer, 61		affects expression	EXP	1	86,046,444	86,049,650	RGD:6480464	CTD
G	CYR61	cysteine-rich, angiogenic inducer, 61		increases expression	EXP	1	86,046,444	86,049,650	RGD:6480464	CTD
G	CYTL1	cytokine-like 1		decreases expression	EXP	4	5,016,313	5,021,197	RGD:6480464	CTD
G	DAB2	Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)		affects expression	EXP	5	39,371,776	39,425,335	RGD:6480464	CTD
G	DAPK1	death-associated protein kinase 1		affects expression	EXP	9	90,112,756	90,323,549	RGD:6480464	CTD
G	DAPK1	death-associated protein kinase 1		decreases expression	EXP	9	90,112,756	90,323,549	RGD:6480464	CTD
G	DARS	aspartyl-tRNA synthetase		affects expression	EXP	2	136,664,254	136,743,222	RGD:6480464	CTD
G	DCAF11	DDB1 and CUL4 associated factor 11		affects expression	EXP	14	24,583,906	24,594,451	RGD:6480464	CTD
G	DCAF13	DDB1 and CUL4 associated factor 13		affects expression	EXP	8	104,426,942	104,455,681	RGD:6480464	CTD
G	DCAF16	DDB1 and CUL4 associated factor 16		affects expression	EXP	4	17,802,278	17,812,381	RGD:6480464	CTD
G	DCAF4	DDB1 and CUL4 associated factor 4		affects expression	EXP	14	73,393,040	73,426,357	RGD:6480464	CTD
G	DCLRE1A	DNA cross-link repair 1A		affects expression	EXP	10	115,594,484	115,613,859	RGD:6480464	CTD
G	DCTN3	dynactin 3 (p22)		affects expression	EXP	9	34,613,548	34,620,496	RGD:6480464	CTD
G	DCTPP1	dCTP pyrophosphatase 1		affects expression	EXP	16	30,435,019	30,441,373	RGD:6480464	CTD
G	DDB2	damage-specific DNA binding protein 2, 48kDa		affects expression	EXP	11	47,236,493	47,260,769	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		affects expression	EXP	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		increases expression	EXP	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		multiple interactions	ISO	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT3	DNA-damage-inducible transcript 3		increases expression	ISO	12	57,910,371	57,914,300	RGD:6480464	CTD
G	DDIT4	DNA-damage-inducible transcript 4		affects expression	EXP	10	74,033,677	74,035,797	RGD:6480464	CTD
G	DDIT4	DNA-damage-inducible transcript 4		increases expression	EXP	10	74,033,677	74,035,797	RGD:6480464	CTD
G	DDR2	discoidin domain receptor tyrosine kinase 2		decreases expression	EXP	1	162,602,228	162,750,255	RGD:6480464	CTD
G	DDX1	DEAD (Asp-Glu-Ala-Asp) box helicase 1		affects expression	EXP	2	15,731,745	15,771,235	RGD:6480464	CTD
G	DDX10	DEAD (Asp-Glu-Ala-Asp) box polypeptide 10		affects expression	EXP	11	108,535,816	108,811,650	RGD:6480464	CTD
G	DDX20	DEAD (Asp-Glu-Ala-Asp) box polypeptide 20		affects expression	EXP	1	112,298,190	112,310,199	RGD:6480464	CTD
G	DDX42	DEAD (Asp-Glu-Ala-Asp) box polypeptide 42		increases expression	EXP	17	61,851,567	61,896,677	RGD:6480464	CTD
G	DDX47	DEAD (Asp-Glu-Ala-Asp) box polypeptide 47		affects expression	EXP	12	12,966,280	12,982,915	RGD:6480464	CTD
G	DDX5	DEAD (Asp-Glu-Ala-Asp) box helicase 5		affects expression	EXP	17	62,494,374	62,502,484	RGD:6480464	CTD
G	DDX50	DEAD (Asp-Glu-Ala-Asp) box polypeptide 50		affects expression	EXP	10	70,661,034	70,706,603	RGD:6480464	CTD
G	DDX56	DEAD (Asp-Glu-Ala-Asp) box helicase 56		affects expression	EXP	7	44,605,016	44,614,137	RGD:6480464	CTD
G	DEF6	differentially expressed in FDCP 6 homolog (mouse)		affects expression	EXP	6	35,265,595	35,289,548	RGD:6480464	CTD
G	DEF8	differentially expressed in FDCP 8 homolog (mouse)		affects expression	EXP	16	90,015,139	90,034,468	RGD:6480464	CTD
G	DEFB1	defensin, beta 1		affects expression	EXP	8	6,728,097	6,735,529	RGD:6480464	CTD
G	DEPDC7	DEP domain containing 7		affects expression	EXP	11	33,037,410	33,055,128	RGD:6480464	CTD
G	DET1	de-etiolated homolog 1 (Arabidopsis)		affects expression	EXP	15	89,055,714	89,089,912	RGD:6480464	CTD
G	DHCR7	7-dehydrocholesterol reductase		multiple interactions	EXP	11	71,145,457	71,159,477	RGD:6480464	CTD
G	DHDH	dihydrodiol dehydrogenase (dimeric)		affects expression	EXP	19	49,436,939	49,448,226	RGD:6480464	CTD
G	DHRS2	dehydrogenase/reductase (SDR family) member 2		affects expression	EXP	14	24,105,573	24,114,848	RGD:6480464	CTD
G	DHRS3	dehydrogenase/reductase (SDR family) member 3		affects expression	EXP	1	12,627,939	12,677,820	RGD:6480464	CTD
G	DHX15	DEAH (Asp-Glu-Ala-His) box polypeptide 15		affects expression	EXP	4	24,529,087	24,586,184	RGD:6480464	CTD
G	DHX34	DEAH (Asp-Glu-Ala-His) box polypeptide 34		affects expression	EXP	19	47,852,538	47,885,961	RGD:6480464	CTD
G	DHX9	DEAH (Asp-Glu-Ala-His) box polypeptide 9		affects expression	EXP	1	182,808,439	182,857,117	RGD:6480464	CTD
G	DIABLO	diablo, IAP-binding mitochondrial protein		multiple interactions	ISO	12	122,692,209	122,712,068	RGD:6480464	CTD
G	DIABLO	diablo, IAP-binding mitochondrial protein		increases secretion	ISO	12	122,692,209	122,712,068	RGD:6480464	CTD
G	DIABLO	diablo, IAP-binding mitochondrial protein		multiple interactions	ISO	12	122,692,209	122,712,068	RGD:6480464	CTD
G	DIABLO	diablo, IAP-binding mitochondrial protein		increases secretion	ISO	12	122,692,209	122,712,068	RGD:6480464	CTD
G	DIEXF	digestive organ expansion factor homolog (zebrafish)		affects expression	EXP	1	210,001,312	210,030,910	RGD:6480464	CTD
G	DIMT1	DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae)		affects expression	EXP	5	61,684,351	61,699,728	RGD:6480464	CTD
G	DIO2	deiodinase, iodothyronine, type II		multiple interactions	ISO	14	80,663,868	80,697,397	RGD:6480464	CTD
G	DIO3	deiodinase, iodothyronine, type III		multiple interactions	ISO	14	102,027,688	102,029,789	RGD:6480464	CTD
G	DIO3	deiodinase, iodothyronine, type III		increases activity	ISO	14	102,027,688	102,029,789	RGD:6480464	CTD
G	DIO3	deiodinase, iodothyronine, type III		increases expression	ISO	14	102,027,688	102,029,789	RGD:6480464	CTD
G	DKC1	dyskeratosis congenita 1, dyskerin		affects expression	EXP	X	153,991,031	154,005,964	RGD:6480464	CTD
G	DKK1	dickkopf 1 homolog (Xenopus laevis)		increases expression	EXP	10	54,074,041	54,077,417	RGD:6480464	CTD
G	DKK1	dickkopf 1 homolog (Xenopus laevis)		affects expression	EXP	10	54,074,041	54,077,417	RGD:6480464	CTD
G	DLD	dihydrolipoamide dehydrogenase		multiple interactions	ISO	7	107,531,586	107,561,643	RGD:6480464	CTD
G	DLEU1	deleted in lymphocytic leukemia 1 (non-protein coding)		affects expression	EXP	13	50,656,414	50,679,433	RGD:6480464	CTD
G	DLX4	distal-less homeobox 4		affects expression	EXP	17	48,046,562	48,052,323	RGD:6480464	CTD
G	DNAJA1	DnaJ (Hsp40) homolog, subfamily A, member 1		affects expression	EXP	9	33,025,209	33,039,062	RGD:6480464	CTD
G	DNAJB1	DnaJ (Hsp40) homolog, subfamily B, member 1		decreases response to substance	EXP	19	14,625,582	14,629,201	RGD:6480464	CTD
G	DNAJC22	DnaJ (Hsp40) homolog, subfamily C, member 22		affects expression	EXP	12	49,741,041	49,745,697	RGD:6480464	CTD
G	DNAJC25-GNG10	DNAJC25-GNG10 readthrough		affects expression	EXP	9	114,393,632	114,432,526	RGD:6480464	CTD
G	DNAJC7	DnaJ (Hsp40) homolog, subfamily C, member 7		affects expression	EXP	17	40,128,439	40,169,715	RGD:6480464	CTD
G	DNHD1	dynein heavy chain domain 1		affects expression	EXP	11	6,518,526	6,593,255	RGD:6480464	CTD
G	DNMT1	DNA (cytosine-5-)-methyltransferase 1		increases expression	EXP	19	10,244,022	10,305,755	RGD:6480464	CTD
G	DNMT1	DNA (cytosine-5-)-methyltransferase 1		decreases response to substance	EXP	19	10,244,022	10,305,755	RGD:6480464	CTD
G	DNMT1	DNA (cytosine-5-)-methyltransferase 1		decreases response to substance	ISO	19	10,244,022	10,305,755	RGD:6480464	CTD
G	DNMT3B	DNA (cytosine-5-)-methyltransferase 3 beta		decreases response to substance	EXP	20	31,350,191	31,397,162	RGD:6480464	CTD
G	DNMT3L	DNA (cytosine-5-)-methyltransferase 3-like		affects expression	EXP	21	45,666,222	45,682,099	RGD:6480464	CTD
G	DNPH1	2'-deoxynucleoside 5'-phosphate N-hydrolase 1		decreases expression	EXP	6	43,193,367	43,197,211	RGD:6480464	CTD
G	DOLK	dolichol kinase		affects expression	EXP	9	131,707,809	131,710,012	RGD:6480464	CTD
G	DOPEY1	dopey family member 1		affects expression	EXP	6	83,777,385	83,878,190	RGD:6480464	CTD
G	DPH2	DPH2 homolog (S. cerevisiae)		affects expression	EXP	1	44,435,653	44,439,043	RGD:6480464	CTD
G	DPM1	dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit		affects expression	EXP	20	49,551,405	49,575,060	RGD:6480464	CTD
G	DPP3	dipeptidyl-peptidase 3		decreases response to substance	EXP	11	66,247,484	66,277,130	RGD:6480464	CTD
G	DPYS	dihydropyrimidinase		affects expression	EXP	8	105,391,652	105,479,277	RGD:6480464	CTD
G	DPYSL3	dihydropyrimidinase-like 3		affects expression	EXP	5	146,770,371	146,889,619	RGD:6480464	CTD
G	DR1	down-regulator of transcription 1, TBP-binding (negative cofactor 2)		affects expression	EXP	1	93,811,478	93,828,149	RGD:6480464	CTD
G	DSCR9	Down syndrome critical region gene 9 (non-protein coding)		affects expression	EXP	21	38,580,804	38,594,037	RGD:6480464	CTD
G	DTX3	deltex homolog 3 (Drosophila)		affects expression	EXP	12	57,998,604	58,003,583	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		increases expression	ISO	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		affects expression	EXP	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		increases expression	EXP	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP1	dual specificity phosphatase 1		multiple interactions	ISO	5	172,195,093	172,198,203	RGD:6480464	CTD
G	DUSP14	dual specificity phosphatase 14		increases expression	EXP	17	35,849,951	35,873,588	RGD:6480464	CTD
G	DUSP2	dual specificity phosphatase 2		affects expression	EXP	2	96,808,908	96,811,179	RGD:6480464	CTD
G	DUSP26	dual specificity phosphatase 26 (putative)		affects expression	EXP	8	33,448,851	33,457,439	RGD:6480464	CTD
G	DUSP5	dual specificity phosphatase 5		increases expression	EXP	10	112,257,625	112,271,302	RGD:6480464	CTD
G	DUSP6	dual specificity phosphatase 6		affects expression	EXP	12	89,741,837	89,746,296	RGD:6480464	CTD
G	DYNLL1	dynein, light chain, LC8-type 1		decreases expression	EXP	12	120,907,660	120,936,298	RGD:6480464	CTD
G	DYRK1A	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A		affects expression	EXP	21	38,739,859	38,887,679	RGD:6480464	CTD
G	DZIP3	DAZ interacting protein 3, zinc finger		affects expression	EXP	3	108,308,337	108,413,693	RGD:6480464	CTD
G	E2F2	E2F transcription factor 2		affects expression	EXP	1	23,832,920	23,857,712	RGD:6480464	CTD
G	EGR2	early growth response 2		affects expression	EXP	10	64,571,756	64,578,927	RGD:6480464	CTD
G	EGR4	early growth response 4		affects expression	EXP	2	73,518,057	73,520,829	RGD:6480464	CTD
G	EIF2AK3	eukaryotic translation initiation factor 2-alpha kinase 3		affects expression	EXP	2	88,856,259	88,927,094	RGD:6480464	CTD
G	EIF3J	eukaryotic translation initiation factor 3, subunit J		affects expression	EXP	15	44,829,266	44,855,001	RGD:6480464	CTD
G	EIF4A2	eukaryotic translation initiation factor 4A2		affects expression	EXP	3	186,501,361	186,507,686	RGD:6480464	CTD
G	EIF4A3	eukaryotic translation initiation factor 4A3		affects expression	EXP	17	78,109,013	78,120,982	RGD:6480464	CTD
G	EIF5	eukaryotic translation initiation factor 5		affects expression	EXP	14	103,800,339	103,811,362	RGD:6480464	CTD
G	ELF2	E74-like factor 2 (ets domain transcription factor)		affects expression	EXP	4	139,978,871	140,060,606	RGD:6480464	CTD
G	ELK1	ELK1, member of ETS oncogene family		decreases expression	EXP	X	47,494,919	47,510,003	RGD:6480464	CTD
G	ELL2	elongation factor, RNA polymerase II, 2		affects expression	EXP	5	95,220,802	95,297,775	RGD:6480464	CTD
G	EMP1	epithelial membrane protein 1		affects expression	EXP	12	13,349,602	13,369,708	RGD:6480464	CTD
G	ENC1	ectodermal-neural cortex 1 (with BTB domain)		affects expression	EXP	5	73,923,231	73,937,249	RGD:6480464	CTD
G	ENDOG	endonuclease G		multiple interactions	ISO	9	131,580,779	131,584,955	RGD:6480464	CTD
G	EPAS1	endothelial PAS domain protein 1		multiple interactions	EXP	2	46,524,541	46,613,842	RGD:6480464	CTD
G	EPAS1	endothelial PAS domain protein 1		affects expression	EXP	2	46,524,541	46,613,842	RGD:6480464	CTD
G	EPAS1	endothelial PAS domain protein 1		increases expression	EXP	2	46,524,541	46,613,842	RGD:6480464	CTD
G	EPB41L1	erythrocyte membrane protein band 4.1-like 1		affects expression	EXP	20	34,679,426	34,820,721	RGD:6480464	CTD
G	EPB41L4A-AS1	EPB41L4A antisense RNA 1		affects expression	EXP	5	111,496,223	111,498,198	RGD:6480464	CTD
G	EPB41L5	erythrocyte membrane protein band 4.1 like 5		affects expression	EXP	2	120,770,604	120,936,697	RGD:6480464	CTD
G	EPC1	enhancer of polycomb homolog 1 (Drosophila)		affects expression	EXP	10	32,557,859	32,636,113	RGD:6480464	CTD
G	EPHA2	EPH receptor A2		affects expression	EXP	1	16,450,832	16,482,582	RGD:6480464	CTD
G	EPHX2	epoxide hydrolase 2, cytoplasmic		increases expression	ISO	8	27,348,519	27,402,439	RGD:6480464	CTD
G	EPHX2	epoxide hydrolase 2, cytoplasmic		affects expression	EXP	8	27,348,519	27,402,439	RGD:6480464	CTD
G	EPN3	epsin 3		affects expression	EXP	17	48,610,048	48,621,111	RGD:6480464	CTD
G	EPO	erythropoietin		multiple interactions	EXP	7	100,318,423	100,321,323	RGD:6480464	CTD
G	EPO	erythropoietin		decreases expression	EXP	7	100,318,423	100,321,323	RGD:6480464	CTD
G	EPO	erythropoietin		decreases expression	ISO	7	100,318,423	100,321,323	RGD:6480464	CTD
G	EPO	erythropoietin		multiple interactions	ISO	7	100,318,423	100,321,323	RGD:6480464	CTD
G	EPOR	erythropoietin receptor		affects expression	EXP	19	11,487,881	11,495,018	RGD:6480464	CTD
G	EPPK1	epiplakin 1		affects expression	EXP	8	144,939,912	144,947,434	RGD:6480464	CTD
G	EPRS	glutamyl-prolyl-tRNA synthetase		affects expression	EXP	1	220,141,942	220,220,000	RGD:6480464	CTD
G	EPS8	epidermal growth factor receptor pathway substrate 8		affects expression	EXP	12	15,773,075	15,942,510	RGD:6480464	CTD
G	EPS8L2	EPS8-like 2		affects expression	EXP	11	706,120	727,727	RGD:6480464	CTD
G	EPSTI1	epithelial stromal interaction 1 (breast)		affects expression	EXP	13	43,460,524	43,566,407	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		affects expression	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	ERBB2	v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)		decreases expression	EXP	17	37,844,393	37,884,915	RGD:6480464	CTD
G	EREG	epiregulin		affects expression	EXP	4	75,230,860	75,254,477	RGD:6480464	CTD
G	ETHE1	ethylmalonic encephalopathy 1		affects expression	EXP	19	44,010,871	44,031,396	RGD:6480464	CTD
G	ETS2	v-ets erythroblastosis virus E26 oncogene homolog 2 (avian)		affects expression	EXP	21	40,177,231	40,196,879	RGD:6480464	CTD
G	EWSR1	Ewing sarcoma breakpoint region 1		affects expression	EXP	22	29,663,998	29,696,515	RGD:6480464	CTD
G	EXOSC3	exosome component 3		affects expression	EXP	9	37,779,711	37,785,089	RGD:6480464	CTD
G	EXOSC4	exosome component 4		affects expression	EXP	8	145,133,522	145,135,551	RGD:6480464	CTD
G	EXOSC9	exosome component 9		affects expression	EXP	4	122,722,472	122,738,176	RGD:6480464	CTD
G	EZH2	enhancer of zeste homolog 2 (Drosophila)		affects expression	EXP	7	148,504,464	148,581,441	RGD:6480464	CTD
G	EZR	ezrin		affects expression	EXP	6	159,186,773	159,240,456	RGD:6480464	CTD
G	F11R	F11 receptor		affects expression	EXP	1	160,965,001	160,991,133	RGD:6480464	CTD
G	F2R	coagulation factor II (thrombin) receptor		affects expression	EXP	5	76,011,868	76,031,595	RGD:6480464	CTD
G	F2R	coagulation factor II (thrombin) receptor		increases expression	EXP	5	76,011,868	76,031,595	RGD:6480464	CTD
G	F7	coagulation factor VII (serum prothrombin conversion accelerator)		affects expression	EXP	13	113,760,102	113,774,995	RGD:6480464	CTD
G	FABP1	fatty acid binding protein 1, liver		affects expression	EXP	2	88,422,501	88,427,650	RGD:6480464	CTD
G	FAM105A	family with sequence similarity 105, member A		affects expression	EXP	5	14,581,891	14,616,289	RGD:6480464	CTD
G	FAM117A	family with sequence similarity 117, member A		affects expression	EXP	17	47,787,687	47,841,518	RGD:6480464	CTD
G	FAM118B	family with sequence similarity 118, member B		affects expression	EXP	11	126,081,619	126,132,879	RGD:6480464	CTD
G	FAM151A	family with sequence similarity 151, member A		affects expression	EXP	1	55,074,850	55,089,200	RGD:6480464	CTD
G	FAM156B	family with sequence similarity 156, member B		affects expression	EXP	X	52,928,409	52,937,587	RGD:6480464	CTD
G	FAM160A2	family with sequence similarity 160, member A2		affects expression	EXP	11	6,232,564	6,255,941	RGD:6480464	CTD
G	FAM173B	family with sequence similarity 173, member B		affects expression	EXP	5	10,225,619	10,250,021	RGD:6480464	CTD
G	FAM45B	family with sequence similarity 45, member B (pseudogene)		affects expression	EXP	X	129,628,915	129,631,422	RGD:6480464	CTD
G	FAM46A	family with sequence similarity 46, member A		affects expression	EXP	6	82,455,447	82,462,428	RGD:6480464	CTD
G	FAM46C	family with sequence similarity 46, member C		affects expression	EXP	1	118,148,604	118,171,011	RGD:6480464	CTD
G	FAM63A	family with sequence similarity 63, member A		affects expression	EXP	1	150,969,301	150,980,854	RGD:6480464	CTD
G	FANCE	Fanconi anemia, complementation group E		affects expression	EXP	6	35,420,138	35,434,881	RGD:6480464	CTD
G	FARSB	phenylalanyl-tRNA synthetase, beta subunit		affects expression	EXP	2	223,436,162	223,520,827	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		multiple interactions	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		decreases expression	ISO	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FAS	Fas (TNF receptor superfamily, member 6)		increases expression	EXP	10	90,750,288	90,775,542	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		increases chemical synthesis	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	ISO	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		multiple interactions	EXP	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASLG	Fas ligand (TNF superfamily, member 6)		increases expression	ISO	1	172,628,185	172,636,013	RGD:6480464	CTD
G	FASTKD1	FAST kinase domains 1		affects expression	EXP	2	170,386,259	170,430,424	RGD:6480464	CTD
G	FAXDC2	fatty acid hydroxylase domain containing 2		affects expression	EXP	5	154,198,052	154,230,213	RGD:6480464	CTD
G	FBLN1	fibulin 1		affects expression	EXP	22	45,898,719	45,997,014	RGD:6480464	CTD
G	FBXL15	F-box and leucine-rich repeat protein 15		affects expression	EXP	10	104,179,571	104,182,893	RGD:6480464	CTD
G	FBXL16	F-box and leucine-rich repeat protein 16		affects expression	EXP	16	742,500	755,825	RGD:6480464	CTD
G	FBXL4	F-box and leucine-rich repeat protein 4		affects expression	EXP	6	99,321,601	99,395,849	RGD:6480464	CTD
G	FBXO3	F-box protein 3		affects expression	EXP	11	33,762,490	33,796,071	RGD:6480464	CTD
G	FBXO30	F-box protein 30		affects expression	EXP	6	146,119,271	146,135,921	RGD:6480464	CTD
G	FBXO9	F-box protein 9		affects expression	EXP	6	52,929,796	52,965,671	RGD:6480464	CTD
G	FCGR3B	Fc fragment of IgG, low affinity IIIb, receptor (CD16b)		multiple interactions	EXP	1	161,592,986	161,601,753	RGD:6480464	CTD
G	FDFT1	farnesyl-diphosphate farnesyltransferase 1		multiple interactions	EXP	8	11,660,190	11,696,818	RGD:6480464	CTD
G	FDPS	farnesyl diphosphate synthase		multiple interactions	EXP	1	155,278,539	155,290,457	RGD:6480464	CTD
G	FDX1	ferredoxin 1		increases expression	ISO	11	110,300,661	110,335,608	RGD:6480464	CTD
G	FDXR	ferredoxin reductase		increases expression	EXP	17	72,858,619	72,869,156	RGD:6480464	CTD
G	FECH	ferrochelatase		decreases expression	EXP	18	55,212,073	55,253,969	RGD:6480464	CTD
G	FEN1	flap structure-specific endonuclease 1		decreases expression	EXP	11	61,560,109	61,564,716	RGD:6480464	CTD
G	FER1L4	fer-1-like 4 (C. elegans) pseudogene		affects expression	EXP	20	34,146,507	34,195,484	RGD:6480464	CTD
G	FGD3	FYVE, RhoGEF and PH domain containing 3		affects expression	EXP	9	95,709,601	95,798,518	RGD:6480464	CTD
G	FGF1	fibroblast growth factor 1 (acidic)		decreases response to substance	ISO	5	141,971,743	142,077,635	RGD:6480464	CTD
G	FGF2	fibroblast growth factor 2 (basic)		multiple interactions	EXP	4	123,747,863	123,819,390	RGD:6480464	CTD
G	FGF7	fibroblast growth factor 7		decreases response to substance	EXP	15	49,715,375	49,779,523	RGD:6480464	CTD
G	FGFBP1	fibroblast growth factor binding protein 1		affects expression	EXP	4	15,937,192	15,940,363	RGD:6480464	CTD
G	FGFR1	fibroblast growth factor receptor 1		multiple interactions	EXP	8	38,268,656	38,326,352	RGD:6480464	CTD
G	FGFR1	fibroblast growth factor receptor 1		decreases expression	EXP	8	38,268,656	38,326,352	RGD:6480464	CTD
G	FGFR1OP	FGFR1 oncogene partner		affects expression	EXP	6	167,412,816	167,454,066	RGD:6480464	CTD
G	FGFR2	fibroblast growth factor receptor 2		affects expression	EXP	10	123,237,844	123,357,972	RGD:6480464	CTD
G	FGFR2	fibroblast growth factor receptor 2		decreases expression	ISO	10	123,237,844	123,357,972	RGD:6480464	CTD
G	FGFR2	fibroblast growth factor receptor 2		multiple interactions	ISO	10	123,237,844	123,357,972	RGD:6480464	CTD
G	FGG	fibrinogen gamma chain		affects expression	EXP	4	155,525,286	155,533,902	RGD:6480464	CTD
G	FGG	fibrinogen gamma chain		increases expression	EXP	4	155,525,286	155,533,902	RGD:6480464	CTD
G	FH	fumarate hydratase		affects expression	EXP	1	241,660,857	241,683,085	RGD:6480464	CTD
G	FHL2	four and a half LIM domains 2		affects expression	EXP	2	105,977,283	106,055,230	RGD:6480464	CTD
G	FIGNL1	fidgetin-like 1		affects expression	EXP	7	50,511,831	50,518,088	RGD:6480464	CTD
G	FJX1	four jointed box 1 (Drosophila)		affects expression	EXP	11	35,639,735	35,642,421	RGD:6480464	CTD
G	FKBP1A	FK506 binding protein 1A, 12kDa		increases expression	ISO	20	1,349,621	1,373,816	RGD:6480464	CTD
G	FLCN	folliculin		affects expression	EXP	17	17,115,526	17,140,502	RGD:6480464	CTD
G	FLRT3	fibronectin leucine rich transmembrane protein 3		affects expression	EXP	20	14,304,639	14,318,313	RGD:6480464	CTD
G	FMO1	flavin containing monooxygenase 1		decreases expression	EXP	1	171,217,663	171,255,113	RGD:6480464	CTD
G	FMOD	fibromodulin		affects expression	EXP	1	203,309,752	203,320,289	RGD:6480464	CTD
G	FN1	fibronectin 1		multiple interactions	EXP	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FN1	fibronectin 1		increases expression	EXP	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FN1	fibronectin 1		increases secretion	EXP	2	216,225,177	216,300,791	RGD:6480464	CTD
G	FNBP1L	formin binding protein 1-like		affects expression	EXP	1	93,913,688	94,020,218	RGD:6480464	CTD
G	FNDC3A	fibronectin type III domain containing 3A		affects expression	EXP	13	49,550,048	49,783,915	RGD:6480464	CTD
G	FOLR1	folate receptor 1 (adult)		affects expression	EXP	11	71,900,602	71,907,367	RGD:6480464	CTD
G	FOLR1	folate receptor 1 (adult)		increases expression	ISO	11	71,900,602	71,907,367	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		multiple interactions	EXP	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		multiple interactions	EXP	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		decreases expression	EXP	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		increases expression	EXP	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FOS	FBJ murine osteosarcoma viral oncogene homolog		multiple interactions	ISO	14	75,745,481	75,748,937	RGD:6480464	CTD
G	FTL	ferritin, light polypeptide		increases expression	EXP	19	49,468,566	49,470,136	RGD:6480464	CTD
G	FTL	ferritin, light polypeptide		increases degradation	EXP	19	49,468,566	49,470,136	RGD:6480464	CTD
G	FTL	ferritin, light polypeptide		multiple interactions	EXP	19	49,468,566	49,470,136	RGD:6480464	CTD
G	FTMT	ferritin mitochondrial		increases expression	ISO	5	121,187,650	121,188,528	RGD:6480464	CTD
G	FUT1	fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)		affects expression	EXP	19	49,251,268	49,258,647	RGD:6480464	CTD
G	FXR1	fragile X mental retardation, autosomal homolog 1		affects expression	EXP	3	180,630,234	180,700,541	RGD:6480464	CTD
G	FXYD5	FXYD domain containing ion transport regulator 5		increases expression	ISO	19	35,645,625	35,660,788	RGD:6480464	CTD
G	FYTTD1	forty-two-three domain containing 1		affects expression	EXP	3	197,476,424	197,511,317	RGD:6480464	CTD
G	FZD2	frizzled family receptor 2		affects expression	EXP	17	42,634,812	42,638,630	RGD:6480464	CTD
G	FZD4	frizzled family receptor 4		affects expression	EXP	11	86,656,717	86,666,440	RGD:6480464	CTD
G	FZD5	frizzled family receptor 5		affects expression	EXP	2	208,627,310	208,634,143	RGD:6480464	CTD
G	FZD6	frizzled family receptor 6		affects expression	EXP	8	104,310,661	104,345,094	RGD:6480464	CTD
G	FZD7	frizzled family receptor 7		affects expression	EXP	2	202,899,310	202,903,160	RGD:6480464	CTD
G	G0S2	G0/G1switch 2		affects expression	EXP	1	209,848,670	209,849,735	RGD:6480464	CTD
G	G3BP2	GTPase activating protein (SH3 domain) binding protein 2		affects expression	EXP	4	76,567,953	76,598,667	RGD:6480464	CTD
G	G6PD	glucose-6-phosphate dehydrogenase		increases activity	EXP	X	153,759,606	153,775,787	RGD:6480464	CTD
G	G6PD	glucose-6-phosphate dehydrogenase		increases activity	ISO	X	153,759,606	153,775,787	RGD:6480464	CTD
G	GAA	glucosidase, alpha; acid		affects expression	EXP	17	78,075,355	78,093,679	RGD:6480464	CTD
G	GAB2	GRB2-associated binding protein 2		affects expression	EXP	11	77,926,336	78,128,868	RGD:6480464	CTD
G	GABARAPL1	GABA(A) receptor-associated protein like 1		affects expression	EXP	12	10,365,489	10,375,727	RGD:6480464	CTD
G	GABPB2	GA binding protein transcription factor, beta subunit 2		affects expression	EXP	1	151,043,080	151,091,007	RGD:6480464	CTD
G	GAD1	glutamate decarboxylase 1 (brain, 67kDa)		decreases response to substance	EXP	2	171,673,200	171,717,661	RGD:6480464	CTD
G	GAD1	glutamate decarboxylase 1 (brain, 67kDa)		affects expression	EXP	2	171,673,200	171,717,661	RGD:6480464	CTD
G	GADD45A	growth arrest and DNA-damage-inducible, alpha		multiple interactions	EXP	1	68,150,860	68,154,021	RGD:6480464	CTD
G	GAL	galanin/GMAP prepropeptide		affects expression	EXP	11	68,451,983	68,458,643	RGD:6480464	CTD
G	GAL3ST1	galactose-3-O-sulfotransferase 1		affects expression	EXP	22	30,950,624	30,960,876	RGD:6480464	CTD
G	GALM	galactose mutarotase (aldose 1-epimerase)		affects expression	EXP	2	38,893,052	38,961,909	RGD:6480464	CTD
G	GAPDH	glyceraldehyde-3-phosphate dehydrogenase		increases expression	EXP	12	6,643,585	6,647,537	RGD:6480464	CTD
G	GAPDH	glyceraldehyde-3-phosphate dehydrogenase		decreases expression	EXP	12	6,643,585	6,647,537	RGD:6480464	CTD
G	GAPDH	glyceraldehyde-3-phosphate dehydrogenase		affects expression	ISO	12	6,643,585	6,647,537	RGD:6480464	CTD
G	GAREM	GRB2 associated, regulator of MAPK1		affects expression	EXP	18	29,843,484	30,050,447	RGD:6480464	CTD
G	GARNL3	GTPase activating Rap/RanGAP domain-like 3		affects expression	EXP	9	130,026,756	130,155,828	RGD:6480464	CTD
G	GART	phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase		affects expression	EXP	21	34,876,238	34,915,198	RGD:6480464	CTD
G	GAS2L1	growth arrest-specific 2 like 1		affects expression	EXP	22	29,702,997	29,708,774	RGD:6480464	CTD
G	GAS6	growth arrest-specific 6		multiple interactions	ISO	13	114,523,522	114,567,046	RGD:6480464	CTD
G	GATA3	GATA binding protein 3		affects expression	EXP	10	8,096,667	8,117,164	RGD:6480464	CTD
G	GATM	glycine amidinotransferase (L-arginine:glycine amidinotransferase)		affects expression	EXP	15	45,653,322	45,670,980	RGD:6480464	CTD
G	GCHFR	GTP cyclohydrolase I feedback regulator		affects expression	EXP	15	41,056,285	41,059,911	RGD:6480464	CTD
G	GCLC	glutamate-cysteine ligase, catalytic subunit		increases expression	EXP	6	53,362,139	53,409,927	RGD:6480464	CTD
G	GCLC	glutamate-cysteine ligase, catalytic subunit		affects expression	EXP	6	53,362,139	53,409,927	RGD:6480464	CTD
G	GCLM	glutamate-cysteine ligase, modifier subunit		increases expression	EXP	1	94,352,590	94,375,012	RGD:6480464	CTD
G	GCNT1	glucosaminyl (N-acetyl) transferase 1, core 2		affects expression	EXP	9	79,056,582	79,122,332	RGD:6480464	CTD
G	GCNT3	glucosaminyl (N-acetyl) transferase 3, mucin type		affects expression	EXP	15	59,903,982	59,912,210	RGD:6480464	CTD
G	GDF15	growth differentiation factor 15		affects expression	EXP	19	18,496,968	18,499,986	RGD:6480464	CTD
G	GDF15	growth differentiation factor 15		increases expression	EXP	19	18,496,968	18,499,986	RGD:6480464	CTD
G	GDF15	growth differentiation factor 15		increases expression	EXP	19	18,496,968	18,499,986	RGD:6480464	CTD
G	GDNF	glial cell derived neurotrophic factor		decreases expression	ISO	5	37,812,779	37,839,782	RGD:6480464	CTD
G	GDNF	glial cell derived neurotrophic factor		multiple interactions	ISO	5	37,812,779	37,839,782	RGD:6480464	CTD
G	GDPD5	glycerophosphodiester phosphodiesterase domain containing 5		affects expression	EXP	11	75,145,685	75,236,599	RGD:6480464	CTD
G	GEMIN5	gem (nuclear organelle) associated protein 5		affects expression	EXP	5	154,266,976	154,317,776	RGD:6480464	CTD
G	GFAP	glial fibrillary acidic protein		multiple interactions	ISO	17	42,982,994	42,992,920	RGD:6480464	CTD
G	GFAP	glial fibrillary acidic protein		increases expression	ISO	17	42,982,994	42,992,920	RGD:6480464	CTD
G	GFER	growth factor, augmenter of liver regeneration		affects response to substance	EXP	16	2,034,150	2,037,749	RGD:6480464	CTD
G	GGTLC1	gamma-glutamyltransferase light chain 1		affects expression	EXP	20	23,965,690	23,969,416	RGD:6480464	CTD
G	GGTLC2	gamma-glutamyltransferase light chain 2		affects expression	EXP	22	22,988,782	22,990,368	RGD:6480464	CTD
G	GHR	growth hormone receptor		decreases response to substance	ISO	5	42,423,877	42,721,980	RGD:6480464	CTD
G	GINS3	GINS complex subunit 3 (Psf3 homolog)		affects expression	EXP	16	58,426,298	58,440,048	RGD:6480464	CTD
G	GJA1	gap junction protein, alpha 1, 43kDa		increases phosphorylation	ISO	6	121,756,745	121,770,873	RGD:6480464	CTD
G	GJA1	gap junction protein, alpha 1, 43kDa		multiple interactions	ISO	6	121,756,745	121,770,873	RGD:6480464	CTD
G	GJA1	gap junction protein, alpha 1, 43kDa		decreases expression	EXP	6	121,756,745	121,770,873	RGD:6480464	CTD
G	GLB1	galactosidase, beta 1		affects expression	EXP	3	33,038,100	33,138,694	RGD:6480464	CTD
G	GLRX	glutaredoxin (thioltransferase)		increases expression	EXP	5	95,149,553	95,158,577	RGD:6480464	CTD
G	GLS	glutaminase		affects expression	EXP	2	191,745,547	191,830,278	RGD:6480464	CTD
G	GLT8D1	glycosyltransferase 8 domain containing 1		affects expression	EXP	3	52,728,504	52,740,048	RGD:6480464	CTD
G	GLYATL1	glycine-N-acyltransferase-like 1		affects expression	EXP	11	58,695,102	58,724,543	RGD:6480464	CTD
G	GLYCTK	glycerate kinase		affects expression	EXP	3	52,321,836	52,329,272	RGD:6480464	CTD
G	GNAS	GNAS complex locus		decreases expression	EXP	20	57,414,795	57,486,250	RGD:6480464	CTD
G	GNAZ	guanine nucleotide binding protein (G protein), alpha z polypeptide		affects expression	EXP	22	23,412,669	23,467,221	RGD:6480464	CTD
G	GNB1	guanine nucleotide binding protein (G protein), beta polypeptide 1		decreases expression	EXP	1	1,716,725	1,822,526	RGD:6480464	CTD
G	GNB2	guanine nucleotide binding protein (G protein), beta polypeptide 2		decreases expression	EXP	7	100,271,363	100,276,792	RGD:6480464	CTD
G	GNE	glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase		affects expression	EXP	9	36,214,438	36,277,053	RGD:6480464	CTD
G	GNL2	guanine nucleotide binding protein-like 2 (nucleolar)		affects expression	EXP	1	38,032,413	38,061,586	RGD:6480464	CTD
G	GNL3	guanine nucleotide binding protein-like 3 (nucleolar)		affects expression	EXP	3	52,719,936	52,728,513	RGD:6480464	CTD
G	GNRH1	gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)		affects expression	EXP	8	25,276,774	25,282,556	RGD:6480464	CTD
G	GPANK1	G patch domain and ankyrin repeats 1		affects expression	EXP	6	31,629,006	31,634,060	RGD:6480464	CTD
G	GPATCH4	G patch domain containing 4		affects expression	EXP	1	156,564,100	156,571,279	RGD:6480464	CTD
G	GPKOW	G patch domain and KOW motifs		affects expression	EXP	X	48,969,022	48,980,079	RGD:6480464	CTD
G	GPN3	GPN-loop GTPase 3		affects expression	EXP	12	110,890,291	110,906,526	RGD:6480464	CTD
G	GPRC5A	G protein-coupled receptor, family C, group 5, member A		affects expression	EXP	12	13,043,956	13,066,600	RGD:6480464	CTD
G	GPT2	glutamic pyruvate transaminase (alanine aminotransferase) 2		affects expression	EXP	16	46,918,308	46,965,201	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		affects abundance	EXP	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		decreases response to substance	EXP	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		increases reduction	EXP	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		multiple interactions	ISO	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		decreases response to substance	ISO	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		multiple interactions	ISO	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX1	glutathione peroxidase 1		increases metabolic processing	ISO	3	49,394,609	49,395,791	RGD:6480464	CTD
G	GPX2	glutathione peroxidase 2 (gastrointestinal)		increases reduction	EXP	14	65,405,870	65,409,623	RGD:6480464	CTD
G	GPX2	glutathione peroxidase 2 (gastrointestinal)		affects expression	EXP	14	65,405,870	65,409,623	RGD:6480464	CTD
G	GPX2	glutathione peroxidase 2 (gastrointestinal)		increases expression	EXP	14	65,405,870	65,409,623	RGD:6480464	CTD
G	GPX3	glutathione peroxidase 3 (plasma)		multiple interactions	ISO	5	150,399,999	150,408,554	RGD:6480464	CTD
G	GPX4	glutathione peroxidase 4		decreases response to substance	EXP	19	1,103,936	1,106,787	RGD:6480464	CTD
G	GPX4	glutathione peroxidase 4		increases response to substance	ISO	19	1,103,936	1,106,787	RGD:6480464	CTD
G	GPX4	glutathione peroxidase 4		decreases response to substance	ISO	19	1,103,936	1,106,787	RGD:6480464	CTD
G	GPX4	glutathione peroxidase 4		decreases response to substance	ISO	19	1,103,936	1,106,787	RGD:6480464	CTD
G	GPX5	glutathione peroxidase 5 (epididymal androgen-related protein)		affects metabolic processing	ISO	6	28,493,789	28,502,728	RGD:6480464	CTD
G	GRIN2C	glutamate receptor, ionotropic, N-methyl D-aspartate 2C		affects expression	EXP	17	72,838,168	72,856,007	RGD:6480464	CTD
G	GRIN2C	glutamate receptor, ionotropic, N-methyl D-aspartate 2C		increases expression	EXP	17	72,838,168	72,856,007	RGD:6480464	CTD
G	GRK5	G protein-coupled receptor kinase 5		affects expression	EXP	10	120,967,197	121,215,131	RGD:6480464	CTD
G	GRPEL2	GrpE-like 2, mitochondrial (E. coli)		affects expression	EXP	5	148,724,977	148,734,146	RGD:6480464	CTD
G	GSN	gelsolin		affects expression	EXP	9	124,030,380	124,095,120	RGD:6480464	CTD
G	GSR	glutathione reductase		multiple interactions	ISO	8	30,535,578	30,585,486	RGD:6480464	CTD
G	GSR	glutathione reductase		increases activity	EXP	8	30,535,578	30,585,486	RGD:6480464	CTD
G	GSR	glutathione reductase		decreases expression	ISO	8	30,535,578	30,585,486	RGD:6480464	CTD
G	GSR	glutathione reductase		decreases activity	ISO	8	30,535,578	30,585,486	RGD:6480464	CTD
G	GSTA1	glutathione S-transferase alpha 1		affects expression	EXP	6	52,656,178	52,668,664	RGD:6480464	CTD
G	GSTA1	glutathione S-transferase alpha 1		increases expression	ISO	6	52,656,178	52,668,664	RGD:6480464	CTD
G	GSTA2	glutathione S-transferase alpha 2		increases expression	ISO	6	52,614,885	52,628,361	RGD:6480464	CTD
G	GSTA4	glutathione S-transferase alpha 4		multiple interactions	ISO	6	52,842,746	52,860,178	RGD:6480464	CTD
G	GSTA4	glutathione S-transferase alpha 4		decreases response to substance	ISO	6	52,842,746	52,860,178	RGD:6480464	CTD
G	GSTA4	glutathione S-transferase alpha 4		increases expression	ISO	6	52,842,746	52,860,178	RGD:6480464	CTD
G	GSTA5	glutathione S-transferase alpha 5		decreases response to substance	ISO	6	52,696,540	52,710,893	RGD:6480464	CTD
G	GSTA5	glutathione S-transferase alpha 5		affects expression	EXP	6	52,696,540	52,710,893	RGD:6480464	CTD
G	GSTA5	glutathione S-transferase alpha 5		decreases response to substance	ISO	6	52,696,540	52,710,893	RGD:6480464	CTD
G	GSTM2	glutathione S-transferase mu 2 (muscle)		increases expression	ISO	1	110,210,644	110,226,619	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		decreases response to substance	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		affects localization	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		multiple interactions	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		decreases expression	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		decreases expression	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		increases expression	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		increases expression	EXP	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTP1	glutathione S-transferase pi 1		decreases response to substance	ISO	11	67,351,066	67,354,124	RGD:6480464	CTD
G	GSTZ1	glutathione S-transferase zeta 1		affects metabolic processing	EXP	14	77,787,230	77,797,940	RGD:6480464	CTD
G	GTF2B	general transcription factor IIB		decreases expression	EXP	1	89,318,321	89,357,301	RGD:6480464	CTD
G	GTF2H1	general transcription factor IIH, polypeptide 1, 62kDa		affects expression	EXP	11	18,343,816	18,388,590	RGD:6480464	CTD
G	GTF3C6	general transcription factor IIIC, polypeptide 6, alpha 35kDa		affects expression	EXP	6	111,279,763	111,289,091	RGD:6480464	CTD
G	GTPBP4	GTP binding protein 4		affects expression	EXP	10	1,034,349	1,063,708	RGD:6480464	CTD
G	HCCS	holocytochrome c synthase		affects expression	EXP	X	11,129,406	11,141,206	RGD:6480464	CTD
G	HDAC2	histone deacetylase 2		multiple interactions	EXP	6	114,257,320	114,292,359	RGD:6480464	CTD
G	HDAC2	histone deacetylase 2		decreases activity	EXP	6	114,257,320	114,292,359	RGD:6480464	CTD
G	HDAC6	histone deacetylase 6		affects expression	EXP	X	48,660,487	48,683,380	RGD:6480464	CTD
G	HEATR1	HEAT repeat containing 1		affects expression	EXP	1	236,712,305	236,767,841	RGD:6480464	CTD
G	HEPH	hephaestin		affects expression	EXP	X	65,382,433	65,487,231	RGD:6480464	CTD
G	HES1	hairy and enhancer of split 1, (Drosophila)		affects expression	EXP	3	193,853,931	193,856,401	RGD:6480464	CTD
G	HEYL	hairy/enhancer-of-split related with YRPW motif-like		affects expression	EXP	1	40,089,103	40,105,348	RGD:6480464	CTD
G	HGF	hepatocyte growth factor (hepapoietin A; scatter factor)		decreases expression	EXP	7	81,331,444	81,399,452	RGD:6480464	CTD
G	HGFAC	HGF activator		decreases expression	EXP	4	3,443,726	3,451,213	RGD:6480464	CTD
G	HHAT	hedgehog acyltransferase		affects expression	EXP	1	210,501,596	210,849,638	RGD:6480464	CTD
G	HIF1A	hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)		multiple interactions	EXP	14	62,162,119	62,214,977	RGD:6480464	CTD
G	HIF1A	hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)		increases expression	EXP	14	62,162,119	62,214,977	RGD:6480464	CTD
G	HIF1A	hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)		increases expression	EXP	14	62,162,119	62,214,977	RGD:6480464	CTD
G	HIF3A	hypoxia inducible factor 3, alpha subunit		multiple interactions	EXP	19	46,800,303	46,846,690	RGD:6480464	CTD
G	HIF3A	hypoxia inducible factor 3, alpha subunit		increases expression	EXP	19	46,800,303	46,846,690	RGD:6480464	CTD
G	HINT1	histidine triad nucleotide binding protein 1		decreases expression	EXP	5	130,494,875	130,501,034	RGD:6480464	CTD
G	HINT3	histidine triad nucleotide binding protein 3		affects expression	EXP	6	126,277,861	126,301,390	RGD:6480464	CTD
G	HIST1H2AE	histone cluster 1, H2ae		affects expression	EXP	6	26,217,148	26,217,711	RGD:6480464	CTD
G	HIST1H2BB	histone cluster 1, H2bb		affects expression	EXP	6	26,043,455	26,043,885	RGD:6480464	CTD
G	HIST1H2BC	histone cluster 1, H2bc		affects expression	EXP	6	26,123,695	26,124,132	RGD:6480464	CTD
G	HIST1H4C	histone cluster 1, H4c		decreases expression	EXP	6	26,104,176	26,104,565	RGD:6480464	CTD
G	HIST2H2AA3	histone cluster 2, H2aa3		affects expression	EXP	1	149,813,785	149,814,318	RGD:6480464	CTD
G	HIST3H2BB	histone cluster 3, H2bb		affects expression	EXP	1	228,645,808	228,646,259	RGD:6480464	CTD
G	HIST3H3	histone cluster 3, H3		multiple interactions	ISO	1	228,612,546	228,613,026	RGD:6480464	CTD
G	HIST3H3	histone cluster 3, H3		decreases acetylation	ISO	1	228,612,546	228,613,026	RGD:6480464	CTD
G	HIST3H3	histone cluster 3, H3		decreases acetylation	ISO	1	228,612,546	228,613,026	RGD:6480464	CTD
G	HIST3H3	histone cluster 3, H3		multiple interactions	ISO	1	228,612,546	228,613,026	RGD:6480464	CTD
G	HIST4H4	histone cluster 4, H4		multiple interactions	ISO	12	14,923,654	14,924,065	RGD:6480464	CTD
G	HIST4H4	histone cluster 4, H4		decreases acetylation	ISO	12	14,923,654	14,924,065	RGD:6480464	CTD
G	HK2	hexokinase 2		affects expression	EXP	2	75,059,782	75,120,481	RGD:6480464	CTD
G	HLA-C	major histocompatibility complex, class I, C		decreases expression	EXP	6	31,236,526	31,239,913	RGD:6480464	CTD
G	HLCS	holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase)		affects expression	EXP	21	38,123,189	38,362,545	RGD:6480464	CTD
G	HMGA1	high mobility group AT-hook 1		decreases expression	EXP	6	34,204,577	34,214,008	RGD:6480464	CTD
G	HMGB1	high mobility group box 1		affects expression	EXP	13	31,032,877	31,040,081	RGD:6480464	CTD
G	HMGB1	high mobility group box 1		multiple interactions	EXP	13	31,032,877	31,040,081	RGD:6480464	CTD
G	HMGB1	high mobility group box 1		multiple interactions	ISO	13	31,032,877	31,040,081	RGD:6480464	CTD
G	HMGB1	high mobility group box 1		affects localization	ISO	13	31,032,877	31,040,081	RGD:6480464	CTD
G	HMGB1	high mobility group box 1		increases secretion	ISO	13	31,032,877	31,040,081	RGD:6480464	CTD
G	HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase		increases expression	EXP	5	74,632,993	74,657,926	RGD:6480464	CTD
G	HMGCR	3-hydroxy-3-methylglutaryl-CoA reductase		multiple interactions	EXP	5	74,632,993	74,657,926	RGD:6480464	CTD
G	HMGCS1	3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)		multiple interactions	EXP	5	43,287,572	43,313,614	RGD:6480464	CTD
G	HMGCS1	3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)		affects expression	EXP	5	43,287,572	43,313,614	RGD:6480464	CTD
G	HMGCS1	3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble)		increases expression	ISO	5	43,287,572	43,313,614	RGD:6480464	CTD
G	HMGN2P46	high mobility group nucleosomal binding domain 2 pseudogene 46		affects expression	EXP	15	45,803,334	45,848,928	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		increases expression	EXP	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		multiple interactions	EXP	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		multiple interactions	ISO	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		increases expression	EXP	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		increases expression	ISO	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		multiple interactions	ISO	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		increases expression	ISO	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX1	heme oxygenase (decycling) 1		multiple interactions	ISO	22	35,777,060	35,790,207	RGD:6480464	CTD
G	HMOX2	heme oxygenase (decycling) 2		decreases response to substance	EXP	16	4,524,719	4,560,348	RGD:6480464	CTD
G	HNF4A	hepatocyte nuclear factor 4, alpha		multiple interactions	EXP	20	42,984,441	43,061,485	RGD:6480464	CTD
G	HNRNPA3P1	heterogeneous nuclear ribonucleoprotein A3 pseudogene 1		affects expression	EXP	10	44,282,860	44,285,865	RGD:6480464	CTD
G	HNRNPAB	heterogeneous nuclear ribonucleoprotein A/B		affects expression	EXP	5	177,631,508	177,638,184	RGD:6480464	CTD
G	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)		multiple interactions	EXP	14	21,677,295	21,737,638	RGD:6480464	CTD
G	HNRNPD	heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)		affects expression	EXP	4	83,274,467	83,295,149	RGD:6480464	CTD
G	HOMER1	homer homolog 1 (Drosophila)		affects expression	EXP	5	78,669,786	78,809,700	RGD:6480464	CTD
G	HOXA1	homeobox A1		affects expression	EXP	7	27,132,612	27,135,625	RGD:6480464	CTD
G	HOXA4	homeobox A4		affects expression	EXP	7	27,168,126	27,170,399	RGD:6480464	CTD
G	HOXA7	homeobox A7		affects expression	EXP	7	27,193,335	27,196,296	RGD:6480464	CTD
G	HOXB6	homeobox B6		affects expression	EXP	17	46,673,099	46,682,334	RGD:6480464	CTD
G	HOXB9	homeobox B9		affects expression	EXP	17	46,698,518	46,703,835	RGD:6480464	CTD
G	HRAS	v-Ha-ras Harvey rat sarcoma viral oncogene homolog		increases expression	EXP	11	532,242	535,550	RGD:6480464	CTD
G	HRASLS2	HRAS-like suppressor 2		affects expression	EXP	11	63,320,242	63,330,855	RGD:6480464	CTD
G	HSD17B11	hydroxysteroid (17-beta) dehydrogenase 11		affects expression	EXP	4	88,257,691	88,312,455	RGD:6480464	CTD
G	HSD17B2	hydroxysteroid (17-beta) dehydrogenase 2		affects expression	EXP	16	82,068,858	82,132,139	RGD:6480464	CTD
G	HSPA14	heat shock 70kDa protein 14		affects expression	EXP	10	14,880,261	14,913,740	RGD:6480464	CTD
G	HSPA1A	heat shock 70kDa protein 1A		multiple interactions	ISO	6	31,783,291	31,785,719	RGD:6480464	CTD
G	HSPA1A	heat shock 70kDa protein 1A		affects localization	ISO	6	31,783,291	31,785,719	RGD:6480464	CTD
G	HSPA1A	heat shock 70kDa protein 1A		affects expression	EXP	6	31,783,291	31,785,719	RGD:6480464	CTD
G	HSPA1A	heat shock 70kDa protein 1A		multiple interactions	EXP	6	31,783,291	31,785,719	RGD:6480464	CTD
G	HSPA1A	heat shock 70kDa protein 1A		increases expression	EXP	6	31,783,291	31,785,719	RGD:6480464	CTD
G	HSPA1A	heat shock 70kDa protein 1A		multiple interactions	ISO	6	31,783,291	31,785,719	RGD:6480464	CTD
G	HSPA1A	heat shock 70kDa protein 1A		affects localization	ISO	6	31,783,291	31,785,719	RGD:6480464	CTD
G	HSPA1B	heat shock 70kDa protein 1B		increases expression	EXP	6	31,795,512	31,798,031	RGD:6480464	CTD
G	HSPA2	heat shock 70kDa protein 2		affects expression	EXP	14	65,007,186	65,009,955	RGD:6480464	CTD
G	HSPA6	heat shock 70kDa protein 6 (HSP70B')		increases expression	EXP	1	161,494,036	161,496,687	RGD:6480464	CTD
G	HSPB1	heat shock 27kDa protein 1		increases expression	EXP	7	75,931,875	75,933,614	RGD:6480464	CTD
G	HSPB1	heat shock 27kDa protein 1		increases phosphorylation	EXP	7	75,931,875	75,933,614	RGD:6480464	CTD
G	HSPB8	heat shock 22kDa protein 8		increases expression	ISO	12	119,616,595	119,632,551	RGD:6480464	CTD
G	HSPE1	heat shock 10kDa protein 1 (chaperonin 10)		affects expression	EXP	2	198,364,721	198,368,187	RGD:6480464	CTD
G	HTATIP2	HIV-1 Tat interactive protein 2, 30kDa		affects expression	EXP	11	20,385,231	20,405,329	RGD:6480464	CTD
G	HTATSF1	HIV-1 Tat specific factor 1		affects expression	EXP	X	135,579,238	135,594,505	RGD:6480464	CTD
G	HYAL3	hyaluronoglucosaminidase 3		affects expression	EXP	3	50,330,259	50,336,899	RGD:6480464	CTD
G	HYPK	huntingtin interacting protein K		affects expression	EXP	15	44,092,619	44,094,787	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		multiple interactions	EXP	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ICAM1	intercellular adhesion molecule 1		affects expression	EXP	19	10,381,517	10,397,291	RGD:6480464	CTD
G	ID1	inhibitor of DNA binding 1, dominant negative helix-loop-helix protein		affects expression	EXP	20	30,193,086	30,194,318	RGD:6480464	CTD
G	ID1	inhibitor of DNA binding 1, dominant negative helix-loop-helix protein		decreases expression	EXP	20	30,193,086	30,194,318	RGD:6480464	CTD
G	ID2	inhibitor of DNA binding 2, dominant negative helix-loop-helix protein		affects expression	EXP	2	8,822,113	8,824,583	RGD:6480464	CTD
G	ID3	inhibitor of DNA binding 3, dominant negative helix-loop-helix protein		affects expression	EXP	1	23,884,421	23,886,285	RGD:6480464	CTD
G	IER2	immediate early response 2		affects expression	EXP	19	13,261,282	13,265,722	RGD:6480464	CTD
G	IER3	immediate early response 3		affects expression	EXP	6	30,710,976	30,712,327	RGD:6480464	CTD
G	IER3	immediate early response 3		decreases expression	EXP	6	30,710,976	30,712,327	RGD:6480464	CTD
G	IER3	immediate early response 3		increases expression	EXP	6	30,710,976	30,712,327	RGD:6480464	CTD
G	IER5	immediate early response 5		affects expression	EXP	1	181,057,638	181,059,979	RGD:6480464	CTD
G	IFI27	interferon, alpha-inducible protein 27		affects expression	EXP	14	94,577,079	94,583,033	RGD:6480464	CTD
G	IFI27L1	interferon, alpha-inducible protein 27-like 1		affects expression	EXP	14	94,547,639	94,569,060	RGD:6480464	CTD
G	IFIT1	interferon-induced protein with tetratricopeptide repeats 1		affects expression	EXP	10	91,152,303	91,166,244	RGD:6480464	CTD
G	IFITM1	interferon induced transmembrane protein 1		affects expression	EXP	11	313,991	315,272	RGD:6480464	CTD
G	IFITM3	interferon induced transmembrane protein 3		increases expression	ISO	11	319,673	320,914	RGD:6480464	CTD
G	IFITM3	interferon induced transmembrane protein 3		increases expression	ISO	11	319,673	320,914	RGD:6480464	CTD
G	IFNB1	interferon, beta 1, fibroblast		increases expression	EXP	9	21,077,104	21,077,943	RGD:6480464	CTD
G	IFNG	interferon, gamma		multiple interactions	EXP	12	68,548,550	68,553,521	RGD:6480464	CTD
G	IFNG	interferon, gamma		multiple interactions	ISO	12	68,548,550	68,553,521	RGD:6480464	CTD
G	IFNG	interferon, gamma		multiple interactions	ISO	12	68,548,550	68,553,521	RGD:6480464	CTD
G	IFNGR1	interferon gamma receptor 1		affects expression	EXP	6	137,518,621	137,540,567	RGD:6480464	CTD
G	IFRD1	interferon-related developmental regulator 1		affects expression	EXP	7	112,063,199	112,117,258	RGD:6480464	CTD
G	IGF1R	insulin-like growth factor 1 receptor		decreases response to substance	ISO	15	99,192,761	99,507,759	RGD:6480464	CTD
G	IGFBP1	insulin-like growth factor binding protein 1		multiple interactions	ISO	7	45,927,959	45,933,267	RGD:6480464	CTD
G	IGFBP5	insulin-like growth factor binding protein 5		increases expression	EXP	2	217,536,828	217,560,272	RGD:6480464	CTD
G	IGFLR1	IGF-like family receptor 1		affects expression	EXP	19	36,230,151	36,233,351	RGD:6480464	CTD
G	IGSF9	immunoglobulin superfamily, member 9		affects expression	EXP	1	159,896,829	159,915,386	RGD:6480464	CTD
G	IK	IK cytokine, down-regulator of HLA II		affects expression	EXP	5	140,027,384	140,042,065	RGD:6480464	CTD
G	IKBKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta		affects response to substance	ISO	8	42,128,820	42,190,171	RGD:6480464	CTD
G	IKBKE	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon		affects expression	EXP	1	206,643,586	206,670,223	RGD:6480464	CTD
G	IL10	interleukin 10		multiple interactions	ISO	1	206,940,948	206,945,839	RGD:6480464	CTD
G	IL12A	interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)		multiple interactions	ISO	3	159,706,623	159,713,806	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		decreases expression	ISO	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		multiple interactions	ISO	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL12B	interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)		multiple interactions	ISO	5	158,741,791	158,757,481	RGD:6480464	CTD
G	IL18	interleukin 18 (interferon-gamma-inducing factor)		decreases expression	EXP	11	112,013,974	112,034,840	RGD:6480464	CTD
G	IL1B	interleukin 1, beta		multiple interactions	EXP	2	113,587,337	113,594,356	RGD:6480464	CTD
G	IMPAD1	inositol monophosphatase domain containing 1		affects expression	EXP	8	57,870,488	57,906,430	RGD:6480464	CTD
G	ING5	inhibitor of growth family, member 5		affects expression	EXP	2	242,641,456	242,668,896	RGD:6480464	CTD
G	INHBB	inhibin, beta B		increases expression	EXP	2	121,103,719	121,109,383	RGD:6480464	CTD
G	INSIG1	insulin induced gene 1		multiple interactions	EXP	7	155,089,486	155,101,945	RGD:6480464	CTD
G	INTS10	integrator complex subunit 10		affects expression	EXP	8	19,674,918	19,709,589	RGD:6480464	CTD
G	INTS2	integrator complex subunit 2		affects expression	EXP	17	59,942,728	60,005,377	RGD:6480464	CTD
G	IPO4	importin 4		affects expression	EXP	14	24,649,425	24,658,124	RGD:6480464	CTD
G	IPO5	importin 5		affects expression	EXP	13	98,605,929	98,676,550	RGD:6480464	CTD
G	IPO7	importin 7		affects expression	EXP	11	9,406,169	9,469,674	RGD:6480464	CTD
G	IRAK1	interleukin-1 receptor-associated kinase 1		affects expression	EXP	X	153,275,957	153,285,342	RGD:6480464	CTD
G	IRF5	interferon regulatory factor 5		affects expression	EXP	7	128,577,994	128,590,089	RGD:6480464	CTD
G	ITGA3	integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)		decreases expression	EXP	17	48,133,340	48,167,849	RGD:6480464	CTD
G	ITGA5	integrin, alpha 5 (fibronectin receptor, alpha polypeptide)		decreases expression	EXP	12	54,789,045	54,813,050	RGD:6480464	CTD
G	ITGA6	integrin, alpha 6		affects expression	EXP	2	173,292,314	173,371,181	RGD:6480464	CTD
G	ITGA7	integrin, alpha 7		decreases expression	EXP	12	56,078,352	56,106,089	RGD:6480464	CTD
G	ITGAL	integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)		decreases expression	EXP	16	30,483,983	30,534,506	RGD:6480464	CTD
G	ITGAM	integrin, alpha M (complement component 3 receptor 3 subunit)		multiple interactions	EXP	16	31,271,288	31,344,213	RGD:6480464	CTD
G	ITGAV	integrin, alpha V		decreases expression	EXP	2	187,454,790	187,545,628	RGD:6480464	CTD
G	ITGB1	integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)		affects expression	EXP	10	33,189,246	33,247,293	RGD:6480464	CTD
G	ITGB1	integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)		decreases expression	EXP	10	33,189,246	33,247,293	RGD:6480464	CTD
G	ITGB4	integrin, beta 4		decreases expression	EXP	17	73,717,516	73,753,899	RGD:6480464	CTD
G	ITGB5	integrin, beta 5		decreases expression	EXP	3	124,481,795	124,606,144	RGD:6480464	CTD
G	ITGB6	integrin, beta 6		decreases expression	EXP	2	160,958,233	161,056,590	RGD:6480464	CTD
G	ITLN1	intelectin 1 (galactofuranose binding)		affects expression	EXP	1	160,846,330	160,854,960	RGD:6480464	CTD
G	ITPR3	inositol 1,4,5-trisphosphate receptor, type 3		affects expression	EXP	6	33,589,156	33,664,351	RGD:6480464	CTD
G	IVNS1ABP	influenza virus NS1A binding protein		affects expression	EXP	1	185,265,520	185,286,461	RGD:6480464	CTD
G	KDM5A	lysine (K)-specific demethylase 5A		affects expression	EXP	12	389,223	498,620	RGD:6480464	CTD
G	MAP3K5	mitogen-activated protein kinase kinase kinase 5		increases activity	ISO	6	136,878,187	137,113,656	RGD:6480464	CTD
G	MAP3K5	mitogen-activated protein kinase kinase kinase 5		increases expression	ISO	6	136,878,187	137,113,656	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		increases phosphorylation	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK1	mitogen-activated protein kinase 1		multiple interactions	ISO	22	22,113,946	22,221,970	RGD:6480464	CTD
G	MAPK3	mitogen-activated protein kinase 3		multiple interactions	ISO	16	30,125,426	30,134,630	RGD:6480464	CTD
G	MAPK3	mitogen-activated protein kinase 3		increases phosphorylation	ISO	16	30,125,426	30,134,630	RGD:6480464	CTD
G	MAPK3	mitogen-activated protein kinase 3		multiple interactions	ISO	16	30,125,426	30,134,630	RGD:6480464	CTD
G	MPC2	mitochondrial pyruvate carrier 2		affects expression	EXP	1	167,885,913	167,906,307	RGD:6480464	CTD
G	MT-CO2	mitochondrially encoded cytochrome c oxidase II		multiple interactions	EXP	MT	7,586	8,269	RGD:6480464	CTD
G	MT-CO2	mitochondrially encoded cytochrome c oxidase II		increases expression	EXP	MT	7,586	8,269	RGD:6480464	CTD
G	MT1A	metallothionein 1A		multiple interactions	ISO	16	56,672,578	56,673,999	RGD:6480464	CTD
G	MT1A	metallothionein 1A		increases expression	ISO	16	56,672,578	56,673,999	RGD:6480464	CTD
G	MTF1	metal-regulatory transcription factor 1		multiple interactions	ISO	1	38,275,239	38,325,292	RGD:6480464	CTD
G	NCEH1	neutral cholesterol ester hydrolase 1		affects expression	EXP	3	172,348,435	172,429,008	RGD:6480464	CTD
G	NFE2L2	nuclear factor (erythroid-derived 2)-like 2		increases localization	EXP	2	178,095,031	178,129,859	RGD:6480464	CTD
G	NOS3	nitric oxide synthase 3 (endothelial cell)		multiple interactions	EXP	7	150,688,144	150,711,687	RGD:6480464	CTD
G	NOS3	nitric oxide synthase 3 (endothelial cell)		decreases expression	EXP	7	150,688,144	150,711,687	RGD:6480464	CTD
G	PRDX1	peroxiredoxin 1		multiple interactions	ISO	1	45,976,707	45,988,562	RGD:6480464	CTD
G	PROSER2	proline and serine-rich protein 2		affects expression	EXP	10	11,865,397	11,914,276	RGD:6480464	CTD
G	PTGS2	prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)		multiple interactions	EXP	1	186,640,944	186,649,559	RGD:6480464	CTD
G	PTGS2	prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)		increases activity	EXP	1	186,640,944	186,649,559	RGD:6480464	CTD
G	RMDN2	regulator of microtubule dynamics 2		affects expression	EXP	2	38,152,462	38,294,285	RGD:6480464	CTD
G	RPS6KA5	ribosomal protein S6 kinase, 90kDa, polypeptide 5		increases activity	ISO	14	91,337,159	91,526,993	RGD:6480464	CTD
G	SLC18B1	solute carrier family 18, subfamily B, member 1		affects expression	EXP	6	133,090,507	133,119,747	RGD:6480464	CTD
G	SOD1	superoxide dismutase 1, soluble		decreases activity	EXP	21	33,031,935	33,041,244	RGD:6480464	CTD
G	SP1	Sp1 transcription factor		multiple interactions	EXP	12	53,773,979	53,810,230	RGD:6480464	CTD
G	TRAPPC13	trafficking protein particle complex 13		affects expression	EXP	5	64,920,558	64,961,954	RGD:6480464	CTD
G	VEGFA	vascular endothelial growth factor A		multiple interactions	EXP	6	43,737,946	43,754,224	RGD:6480464	CTD
G	VEGFA	vascular endothelial growth factor A		increases expression	EXP	6	43,737,946	43,754,224	RGD:6480464	CTD
G	VEGFA	vascular endothelial growth factor A		increases expression	EXP	6	43,737,946	43,754,224	RGD:6480464	CTD

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	513696
chemical entity	513696
molecular entity	495878
inorganic molecular entity	341571
inorganic oxide	6270
inorganic peroxide	4149
hydrogen peroxide	4149
Path 2
Term	Annotations
CHEBI ontology	513696
subatomic particle	512589
composite particle	512589
hadron	512589
baryon	512589
nucleon	512589
atomic nucleus	512589
atom	512589
main group element atom	480600
p-block element atom	478018
chalcogen	329385
oxygen atom	313772
oxygen molecular entity	313772
oxide	9624
inorganic oxide	6270